Redox signaling in the gastrointestinal tract

Free Radical Biology and Medicine

Volumn 104, Issue , 2017, Pages 75-103

  Pérez, Salvador ^a   Taléns Visconti, Raquel ^a   Rius Pérez, Sergio ^a   Finamor, Isabela ^a   Sastre, Juan ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

APE1 Ref1; Barrett's esophagus; Celiac disease; Colorectal cancer; Dual oxidase 2; Gastric cancer; GPx2; Inflammatory bowel disease; Intestinal epithelium; MnSOD; NADPH oxidase 1; Nrf2; Peptic ulcer

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; CRYOPYRIN; DUOX2 PROTEIN; GLUTATHIONE PEROXIDASE 2; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; MANGANESE SUPEROXIDE DISMUTASE; MUCIN; NONSTEROID ANTIINFLAMMATORY AGENT; NOTCH RECEPTOR; PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOL; TIGAR PROTEIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; WNT PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIOL DERIVATIVE;

BARRETT ESOPHAGUS; CELIAC DISEASE; CELL PROLIFERATION; COLORECTAL CANCER; EPITHELIUM CELL; ESOPHAGEAL ADENOCARCINOMA; GASTROINTESTINAL TRACT; HELICOBACTER INFECTION; HUMAN; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE INJURY; MALIGNANT NEOPLASM; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PEPTIC ULCER; PRIORITY JOURNAL; REDOX SIGNALING; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH ULCER; TIGHT JUNCTION; UPREGULATION; WOUND HEALING; GASTROINTESTINAL DISEASE; GENETICS; INTESTINE; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; WNT SIGNALING;

CELL PROLIFERATION; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; INTESTINES; NADPH OXIDASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SULFHYDRYL COMPOUNDS; WNT SIGNALING PATHWAY;

EID: 85008952981     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.12.048     Document Type: Review

References (437)

1. [1] Laine, L., Takeuchi, K., Tarnawski, A., Gastric mucosal defense and cytoprotection: bench to bedside. Gastroenterology 135 (2008), 41–60, 10.1053/j.gastro.2008.05.030.
2. [2] Bhattacharyya, A., Chattopadhyay, R., Mitra, S., Crowe, S.E., Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol. Rev. 94 (2014), 329–354, 10.1152/physrev.00040.2012.
3. [3] Naito, Y., Yoshikawa, T., Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic. Biol. Med. 33 (2002), 323–336.
4. [4] Moncada, S., Palmer, R.M., Higgs, E.A., Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991), 109–142.
5. [5] Lundberg, J.O., Govoni, M., Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic. Biol. Med. 37 (2004), 395–400, 10.1016/j.freeradbiomed.2004.04.027.
6. [6] Lundberg, J.O., Weitzberg, E., Gladwin, M.T., The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. 7 (2008), 156–167, 10.1038/nrd2466.
7. [7] Duncan, C., Dougall, H., Johnston, P., Green, S., Brogan, R., Leifert, C., Smith, L., Golden, M., Benjamin, N., Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat. Med. 1 (1995), 546–551.
8. [8] Björne H, H., Petersson, J., Phillipson, M., Weitzberg, E., Holm, L., Lundberg, J.O., Nitrite in saliva increases gastric mucosal blood flow and mucus thickness. J. Clin. Investig. 113 (2004), 106–114, 10.1172/JCI19019.
9. [9] Benjamin, N., O'Driscoll, F., Dougall, H., Duncan, C., Smith, L., Golden, M., McKenzie, H., Stomach NO synthesis. Nature, 368, 1994, 502, 10.1038/368502a0.
10. [10] Lundberg, J.O., Weitzberg, E., Lundberg, J.M., Alving, K., Intragastric nitric oxide production in humans: measurements in expelled air. Gut 35 (1994), 1543–1546.
11. [11] Rocha, B.S., Gago, B., Barbosa, R.M., Lundberg, J.O., Radi, R., Laranjinha, J., Intragastric nitration by dietary nitrite: implications for modulation of protein and lipid signaling. Free Radic. Biol. Med. 52 (2012), 693–698, 10.1016/j.freeradbiomed.2011.11.011.
12. [12] Pereira, C., Ferreira, N.R., Rocha, B.S., Barbosa, R.M., Laranjinha, J., The redox interplay between nitrite and nitric oxide: from the gut to the brain. Redox Biol. 1 (2013), 276–284, 10.1016/j.redox.2013.04.004.
13. [13] Sobko, T., Reinders, C., Norin, E., Midtvedt, T., Gustafsson, L.E., Lundberg, J.O., Gastrointestinal nitric oxide generation in germ-free and conventional rats. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004), G993–997, 10.1152/ajpgi.00203.2004.
14. [14] Peri, L., Pietraforte, D., Scorza, G., Napolitano, A., Fogliano, V., Minetti, M., Apples increase nitric oxide production by human saliva at the acidic pH of the stomach: a new biological function for polyphenols with a catechol group?. Free Radic. Biol. Med. 39 (2005), 668–681, 10.1016/j.freeradbiomed.2005.04.021.
15. [15] Gago, B., Lundberg, J.O., Barbosa, R.M., Laranjinha, J., Red wine-dependent reduction of nitrite to nitric oxide in the stomach. Free Radic. Biol. Med. 43 (2007), 1233–1242, 10.1016/j.freeradbiomed.2007.06.007.
16. [16] Rocha, B.S., Gago, B., Barbosa, R.M., Lundberg, J.O., Mann, G.E., Radi, R., Laranjinha, J., Pepsin is nitrated in the rat stomach, acquiring antiulcerogenic activity: a novel interaction between dietary nitrate and gut proteins. Free Radic. Biol. Med. 58 (2013), 26–34, 10.1016/j.freeradbiomed.2012.12.017.
17. [17] Rocha, B.S., Lundberg, J.O., Radi, R., Laranjinha, J., Role of nitrite, urate and pepsin in the gastroprotective effects of saliva. Redox Biol. 8 (2016), 407–414, 10.1016/j.redox.2016.04.002.
18. [18] Jansson, E.A., Petersson, J., Reinders, C., Sobko, T., Björne, H., Phillipson, M., Weitzberg, E., Holm, L., Lundberg, J.O., Protection from nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers by dietary nitrate. Free Radic. Biol. Med. 42 (2007), 510–518, 10.1016/j.freeradbiomed.2006.11.018.
19. [19] Dykhuizen, R.S., Fraser, A., McKenzie, H., Golden, M., Leifert, C., Benjamin, N., Helicobacter pylori is killed by nitrite under acidic conditions. Gut 42 (1998), 334–337.
20. [20] Neish, A.S., Redox signaling mediated by the gut microbiota. Free Radic. Res. 47 (2013), 950–957, 10.3109/10715762.2013.833331.
21. [21] Gerbe, F., van Es, J.H., Makrini, L., Brulin, B., Mellitzer, G., Robine, S., Romagnolo, B., Shroyer, N.F., Bourgaux, J.-F., Pignodel, C., Clevers, H., Jay, P., Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium. J. Cell Biol. 192 (2011), 767–780, 10.1083/jcb.201010127.
22. [22] van der Flier, L.G., Clevers, H., Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu. Rev. Physiol. 71 (2009), 241–260, 10.1146/annurev.physiol.010908.163145.
23. [23] Sato, T., van Es, J.H., Snippert, H.J., Stange, D.E., Vries, R.G., van den Born, M., Barker, N., Shroyer, N.F., van de Wetering, M., Clevers, H., Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469 (2011), 415–418, 10.1038/nature09637.
24. [24] Bjerknes, M., Cheng, H., The stem-cell zone of the small intestinal epithelium. II. Evidence from paneth cells in the newborn mouse. Am. J. Anat. 160 (1981), 65–75, 10.1002/aja.1001600106.
25. [25] Yatabe, Y., Tavaré, S., Shibata, D., Investigating stem cells in human colon by using methylation patterns. Proc. Natl. Acad. Sci. USA 98 (2001), 10839–10844, 10.1073/pnas.191225998.
26. [26] Scoville, D.H., Sato, T., He, X.C., Li, L., Current view: intestinal stem cells and signaling. Gastroenterology 134 (2008), 849–864, 10.1053/j.gastro.2008.01.079.
27. [27] Booth, C., Potten, C.S., Gut instincts: thoughts on intestinal epithelial stem cells. J. Clin. Investig. 105 (2000), 1493–1499, 10.1172/JCI10229.
28. [28] Circu, M.L., Aw, T.Y., Intestinal redox biology and oxidative stress. Semin. Cell Dev. Biol. 23 (2012), 729–737, 10.1016/j.semcdb.2012.03.014.
29. [29] Coant, N., Ben Mkaddem, S., Pedruzzi, E., Guichard, C., Tréton, X., Ducroc, R., Freund, J.-N., Cazals-Hatem, D., Bouhnik, Y., Woerther, P.-L., Skurnik, D., Grodet, A., Fay, M., Biard, D., Lesuffleur, T., Deffert, C., Moreau, R., Groyer, A., Krause, K.-H., Daniel, F., Ogier-Denis, E., NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon. Mol. Cell. Biol. 30 (2010), 2636–2650, 10.1128/MCB.01194-09.
30. [30] Jones, D.P., Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol. 348 (2002), 93–112.
31. [31] Jones, D.P., Redefining oxidative stress. Antioxid. Redox Signal. 8 (2006), 1865–1879, 10.1089/ars.2006.8.1865.
32. [32] Nkabyo, Y.S., Ziegler, T.R., Gu, L.H., Watson, W.H., Jones, D.P., Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells. Am. J. Physiol. Gastrointest. Liver Physiol. 283 (2002), G1352–1359, 10.1152/ajpgi.00183.2002.
33. [33] Aw, T.Y., Biliary glutathione promotes the mucosal metabolism of luminal peroxidized lipids by rat small intestine in vivo. J. Clin. Investig. 94 (1994), 1218–1225, 10.1172/JCI117439.
34. [34] Circu, M.L., Aw, T.Y., Redox biology of the intestine. Free Radic. Res. 45 (2011), 1245–1266, 10.3109/10715762.2011.611509.
35. [35] Aw, T.Y., Wierzbicka, G., Jones, D.P., Oral glutathione increases tissue glutathione in vivo. Chem. Biol. Interact. 80 (1991), 89–97.
36. [36] Samiec, P.S., Dahm, L.J., Jones, D.P., Glutathione S-transferase in mucus of rat small intestine. Toxicol. Sci. 54 (2000), 52–59.
37. [37] Aw, T.Y., Intestinal glutathione: determinant of mucosal peroxide transport, metabolism, and oxidative susceptibility. Toxicol. Appl. Pharmacol. 204 (2005), 320–328, 10.1016/j.taap.2004.11.016.
38. [38] Wolff, S.P., Nourooz-Zadeh, J., Hypothesis: UK consumption of dietary lipid hydroperoxides—a possible contributory factor to atherosclerosis. Atherosclerosis 119 (1996), 261–263.
39. [39] Tsunada, S., Iwakiri, R., Noda, T., Fujimoto, K., Fuseler, J., Rhoads, C.A., Aw, T.Y., Chronic exposure to subtoxic levels of peroxidized lipids suppresses mucosal cell turnover in rat small intestine and reversal by glutathione. Dig. Dis. Sci. 48 (2003), 210–222.
40. [40] Noda, T., Iwakiri, R., Fujimoto, K., Aw, T.Y., Induction of mild intracellular redox imbalance inhibits proliferation of CaCo-2 cells. FASEB J. 15 (2001), 2131–2139, 10.1096/fj.01-0131com.
41. [41] Gotoh, Y., Noda, T., Iwakiri, R., Fujimoto, K., Rhoads, C.A., Aw, T.Y., Lipid peroxide-induced redox imbalance differentially mediates CaCo-2 cell proliferation and growth arrest. Cell Prolif. 35 (2002), 221–235.
42. [42] Jonas, C.R., Ziegler, T.R., Gu, L.H., Jones, D.P., Extracellular thiol/disulfide redox state affects proliferation rate in a human colon carcinoma (Caco2) cell line. Free Radic. Biol. Med. 33 (2002), 1499–1506.
43. [43] Nkabyo, Y.S., Go, Y.-M., Ziegler, T.R., Jones, D.P., Extracellular cysteine/cystine redox regulates the p44/p42 MAPK pathway by metalloproteinase-dependent epidermal growth factor receptor signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005), G70–78, 10.1152/ajpgi.00280.2004.
44. [44] Anderson, C.L., Iyer, S.S., Ziegler, T.R., Jones, D.P., Control of extracellular cysteine/cystine redox state by HT-29 cells is independent of cellular glutathione. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293 (2007), R1069–1075, 10.1152/ajpregu.00195.2007.
45. [45] Mannery, Y.O., Ziegler, T.R., Hao, L., Shyntum, Y., Jones, D.P., Characterization of apical and basal thiol-disulfide redox regulation in human colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 299 (2010), G523–530, 10.1152/ajpgi.00359.2009.
46. [46] Gregorieff, A., Pinto, D., Begthel, H., Destrée, O., Kielman, M., Clevers, H., Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 129 (2005), 626–638, 10.1016/j.gastro.2005.06.007.
47. [47] Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., Polakis, P., Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272 (1996), 1023–1026.
48. [48] Amit, S., Hatzubai, A., Birman, Y., Andersen, J.S., Ben-Shushan, E., Mann, M., Ben-Neriah, Y., Alkalay, I., Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev. 16 (2002), 1066–1076, 10.1101/gad.230302.
49. [49] Cavallo, R.A., Cox, R.T., Moline, M.M., Roose, J., Polevoy, G.A., Clevers, H., Peifer, M., Bejsovec, A., Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature 395 (1998), 604–608, 10.1038/26982.
50. [50] Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G., Peters, P.J., Clevers, H., Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 19 (1998), 379–383, 10.1038/1270.
51. [51] Pinto, D., Gregorieff, A., Begthel, H., Clevers, H., Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev. 17 (2003), 1709–1713, 10.1101/gad.267103.
52. [52] Kuhnert, F., Davis, C.R., Wang, H.-T., Chu, P., Lee, M., Yuan, J., Nusse, R., Kuo, C.J., Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc. Natl. Acad. Sci. USA 101 (2004), 266–271, 10.1073/pnas.2536800100.
53. [53] Ireland, H., Kemp, R., Houghton, C., Howard, L., Clarke, A.R., Sansom, O.J., Winton, D.J., Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta-catenin. Gastroenterology 126 (2004), 1236–1246.
54. [54] Fevr, T., Robine, S., Louvard, D., Huelsken, J., Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol. Cell. Biol. 27 (2007), 7551–7559, 10.1128/MCB.01034-07.
55. [55] Kim, K.-A., Kakitani, M., Zhao, J., Oshima, T., Tang, T., Binnerts, M., Liu, Y., Boyle, B., Park, E., Emtage, P., Funk, W.D., Tomizuka, K., Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science 309 (2005), 1256–1259, 10.1126/science.1112521.
56. [56] Sansom, O.J., Reed, K.R., Hayes, A.J., Ireland, H., Brinkmann, H., Newton, I.P., Batlle, E., Simon-Assmann, P., Clevers, H., Nathke, I.S., Clarke, A.R., Winton, D.J., Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev. 18 (2004), 1385–1390, 10.1101/gad.287404.
57. [57] Korinek, V., Barker, N., Moerer, P., van Donselaar, E., Huls, G., Peters, P.J., Clevers, H., Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 19 (1998), 379–383, 10.1038/1270.
58. [58] Yang, Q., Bermingham, N.A., Finegold, M.J., Zoghbi, H.Y., Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 294 (2001), 2155–2158, 10.1126/science.1065718.
59. [59] Fre, S., Huyghe, M., Mourikis, P., Robine, S., Louvard, D., Artavanis-Tsakonas, S., Notch signals control the fate of immature progenitor cells in the intestine. Nature 435 (2005), 964–968, 10.1038/nature03589.
60. [60] van Es, J.H., van Gijn, M.E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D.J., Radtke, F., Clevers, H., Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435 (2005), 959–963, 10.1038/nature03659.
61. [61] Jensen, J., Pedersen, E.E., Galante, P., Hald, J., Heller, R.S., Ishibashi, M., Kageyama, R., Guillemot, F., Serup, P., Madsen, O.D., Control of endodermal endocrine development by Hes-1. Nat. Genet. 24 (2000), 36–44, 10.1038/71657.
62. [62] Jenny, M., Uhl, C., Roche, C., Duluc, I., Guillermin, V., Guillemot, F., Jensen, J., Kedinger, M., Gradwohl, G., Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J. 21 (2002), 6338–6347.
63. [63] Wong, G.T., Manfra, D., Poulet, F.M., Zhang, Q., Josien, H., Bara, T., Engstrom, L., Pinzon-Ortiz, M., Fine, J.S., Lee, H.-J.J., Zhang, L., Higgins, G.A., Parker, E.M., Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J. Biol. Chem. 279 (2004), 12876–12882, 10.1074/jbc.M311652200.
64. [64] Suzuki, K., Fukui, H., Kayahara, T., Sawada, M., Seno, H., Hiai, H., Kageyama, R., Okano, H., Chiba, T., Hes1-deficient mice show precocious differentiation of Paneth cells in the small intestine. Biochem. Biophys. Res. Commun. 328 (2005), 348–352, 10.1016/j.bbrc.2004.12.174.
65. [65] Vooijs, M., Ong, C.-T., Hadland, B., Huppert, S., Liu, Z., Korving, J., van den Born, M., Stappenbeck, T., Wu, Y., Clevers, H., Kopan, R., Mapping the consequence of Notch1 proteolysis in vivo with NIP-CRE. Development 134 (2007), 535–544, 10.1242/dev.02733.
66. [66] Stanger, B.Z., Datar, R., Murtaugh, L.C., Melton, D.A., Direct regulation of intestinal fate by Notch. Proc. Natl. Acad. Sci. USA 102 (2005), 12443–12448, 10.1073/pnas.0505690102.
67. [67] Mills, J.C., Gordon, J.I., The intestinal stem cell niche: there grows the neighborhood. Proc. Natl. Acad. Sci. USA 98 (2001), 12334–12336, 10.1073/pnas.231487198.
68. [68] Powell, D.W., Mifflin, R.C., Valentich, J.D., Crowe, S.E., Saada, J.I., West, A.B., Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am. J. Physiol. 277 (1999), C183–201.
69. [69] Haramis, A.-P.G., Begthel, H., van den Born, M., van Es, J., Jonkheer, S., Offerhaus, G.J.A., Clevers, H., De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 303 (2004), 1684–1686, 10.1126/science.1093587.
70. [70] He, X.C., Zhang, J., Tong, W.-G., Tawfik, O., Ross, J., Scoville, D.H., Tian, Q., Zeng, X., He, X., Wiedemann, L.M., Mishina, Y., Li, L., BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat. Genet. 36 (2004), 1117–1121, 10.1038/ng1430.
71. [71] Massagué, J., Seoane, J., Wotton, D., Smad transcription factors. Genes Dev. 19 (2005), 2783–2810, 10.1101/gad.1350705.
72. [72] Madison, B.B., Braunstein, K., Kuizon, E., Portman, K., Qiao, X.T., Gumucio, D.L., Epithelial hedgehog signals pattern the intestinal crypt-villus axis. Development 132 (2005), 279–289, 10.1242/dev.01576.
73. [73] Karlsson, L., Lindahl, P., Heath, J.K., Betsholtz, C., Abnormal gastrointestinal development in PDGF-A and PDGFR-(alpha) deficient mice implicates a novel mesenchymal structure with putative instructive properties in villus morphogenesis. Development 127 (2000), 3457–3466.
74. [74] Cheung, E.C., Athineos, D., Lee, P., Ridgway, R.A., Lambie, W., Nixon, C., Strathdee, D., Blyth, K., Sansom, O.J., Vousden, K.H., TIGAR is required for efficient intestinal regeneration and tumorigenesis. Dev. Cell. 25 (2013), 463–477, 10.1016/j.devcel.2013.05.001.
75. [75] Cheung, E.C., Lee, P., Ceteci, F., Nixon, C., Blyth, K., Sansom, O.J., Vousden, K.H., Opposing effects of TIGAR- and RAC1-derived ROS on Wnt-driven proliferation in the mouse intestine. Genes Dev. 30 (2016), 52–63, 10.1101/gad.271130.115.
76. [76] Myant, K.B., Cammareri, P., McGhee, E.J., Ridgway, R.A., Huels, D.J., Cordero, J.B., Schwitalla, S., Kalna, G., Ogg, E.-L., Athineos, D., Timpson, P., Vidal, M., Murray, G.I., Greten, F.R., Anderson, K.I., Sansom, O.J., ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell 12 (2013), 761–773, 10.1016/j.stem.2013.04.006.
77. [77] Forman, H.J., Augusto, O., Brigelius-Flohe, R., Dennery, P.A., Kalyanaraman, B., Ischiropoulos, H., Mann, G.E., Radi, R., Roberts, L.J., Vina, J., Davies, K.J.A., Even free radicals should follow some rules: a guide to free radical research terminology and methodology. Free Radic. Biol. Med. 78 (2015), 233–235, 10.1016/j.freeradbiomed.2014.10.504.
78. [78] Geiszt, M., Lekstrom, K., Brenner, S., Hewitt, S.M., Dana, R., Malech, H.L., Leto, T.L., NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes. J. Immunol. 171 (2003), 299–306.
79. [79] Valente, A.J., Zhou, Q., Lu, Z., He, W., Qiang, M., Ma, W., Li, G., Wang, L., Banfi, B., Steger, K., Krause, K.-H., Clark, R.A., Li, S., Regulation of NOX1 expression by GATA, HNF-1alpha, and Cdx transcription factors. Free Radic. Biol. Med. 44 (2008), 430–443, 10.1016/j.freeradbiomed.2007.10.035.
80. [80] Kawahara, T., Kuwano, Y., Teshima-Kondo, S., Takeya, R., Sumimoto, H., Kishi, K., Tsunawaki, S., Hirayama, T., Rokutan, K., Role of nicotinamide adenine dinucleotide phosphate oxidase 1 in oxidative burst response to toll-like receptor 5 signaling in large intestinal epithelial cells. J. Immunol. 172 (2004), 3051–3058.
81. [81] Laurent, E., McCoy, J.W., Macina, R.A., Liu, W., Cheng, G., Robine, S., Papkoff, J., Lambeth, J.D., Nox1 is over-expressed in human colon cancers and correlates with activating mutations in K-Ras. Int. J. Cancer 123 (2008), 100–107, 10.1002/ijc.23423.
82. [82] Kajla, S., Mondol, A.S., Nagasawa, A., Zhang, Y., Kato, M., Matsuno, K., Yabe-Nishimura, C., Kamata, T., A crucial role for Nox 1 in redox-dependent regulation of Wnt-β-catenin signaling. FASEB J. 26 (2012), 2049–2059, 10.1096/fj.11-196360.
83. [83] Lambeth, J.D., Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic. Biol. Med. 43 (2007), 332–347, 10.1016/j.freeradbiomed.2007.03.027.
84. [84] Lambeth, J.D., Kawahara, T., Diebold, B., Regulation of Nox and Duox enzymatic activity and expression. Free Radic. Biol. Med. 43 (2007), 319–331, 10.1016/j.freeradbiomed.2007.03.028.
85. [85] Funato, Y., Michiue, T., Asashima, M., Miki, H., The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled. Nat. Cell Biol. 8 (2006), 501–508, 10.1038/ncb1405.
86. [86] Barrett, C.W., Ning, W., Chen, X., Smith, J.J., Washington, M.K., Hill, K.E., Coburn, L.A., Peek, R.M., Chaturvedi, R., Wilson, K.T., Burk, R.F., Williams, C.S., Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma. Cancer Res. 73 (2013), 1245–1255, 10.1158/0008-5472.CAN-12-3150.
87. [87] Chu, F.F., Esworthy, R.S., The expression of an intestinal form of glutathione peroxidase (GSHPx-GI) in rat intestinal epithelium. Arch. Biochem. Biophys. 323 (1995), 288–294.
88. [88] Chu, F.-F., Esworthy, R.S., Doroshow, J.H., Role of Se-dependent glutathione peroxidases in gastrointestinal inflammation and cancer. Free Radic. Biol. Med. 36 (2004), 1481–1495, 10.1016/j.freeradbiomed.2004.04.010.
89. [89] Sido, B., Giese, T., Autschbach, F., Lasitschka, F., Braunstein, J., Meuer, S.C., Potential role of thioredoxin in immune responses in intestinal lamina propria T lymphocytes. Eur. J. Immunol. 35 (2005), 408–417, 10.1002/eji.200424500.
90. [90] Godoy, J.R., Funke, M., Ackermann, W., Haunhorst, P., Oesteritz, S., Capani, F., Elsässer, H.-P., Lillig, C.H., Redox atlas of the mouse. Immunohistochemical detection of glutaredoxin-, peroxiredoxin-, and thioredoxin-family proteins in various tissues of the laboratory mouse. Biochim. Biophys. Acta 1810 (2011), 2–92, 10.1016/j.bbagen.2010.05.006.
91. [91] Ha, E.-M., Oh, C.-T., Bae, Y.S., Lee, W.-J., A direct role for dual oxidase in Drosophila gut immunity. Science 310 (2005), 847–850, 10.1126/science.1117311.
92. [92] Sommer, F., Bäckhed, F., The gut microbiota engages different signaling pathways to induce Duox2 expression in the ileum and colon epithelium. Mucosal Immunol. 8 (2015), 372–379, 10.1038/mi.2014.74.
93. [93] Liang, S.C., Tan, X.-Y., Luxenberg, D.P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., Fouser, L.A., Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203 (2006), 2271–2279, 10.1084/jem.20061308.
94. [94] Grasberger, H., Gao, J., Nagao-Kitamoto, H., Kitamoto, S., Zhang, M., Kamada, N., Eaton, K.A., El-Zaatari, M., Shreiner, A.B., Merchant, J.L., Owyang, C., Kao, J.Y., Increased expression of DUOX2 is an epithelial response to mucosal dysbiosis required for immune homeostasis in mouse intestine. Gastroenterology 149 (2015), 1849–1859, 10.1053/j.gastro.2015.07.062.
95. [95] Grasberger, H., El-Zaatari, M., Dang, D.T., Merchant, J.L., Dual oxidases control release of hydrogen peroxide by the gastric epithelium to prevent Helicobacter felis infection and inflammation in mice. Gastroenterology 145 (2013), 1045–1054, 10.1053/j.gastro.2013.07.011.
96. [96] Ha, E.-M., Lee, K.-A., Seo, Y.Y., Kim, S.-H., Lim, J.-H., Oh, B.-H., Kim, J., Lee, W.-J., Coordination of multiple dual oxidase-regulatory pathways in responses to commensal and infectious microbes in drosophila gut. Nat. Immunol. 10 (2009), 949–957, 10.1038/ni.1765.
97. [97] Rokutan, K., Kawahara, T., Kuwano, Y., Tominaga, K., Sekiyama, A., Teshima-Kondo, S., NADPH oxidases in the gastrointestinal tract: a potential role of Nox1 in innate immune response and carcinogenesis. Antioxid. Redox Signal. 8 (2006), 1573–1582, 10.1089/ars.2006.8.1573.
98. [98] Fu, X., Kassim, S.Y., Parks, W.C., Heinecke, J.W., Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J. Biol. Chem. 276 (2001), 41279–41287, 10.1074/jbc.M106958200.
99. [99] Wilson, C.L., Ouellette, A.J., Satchell, D.P., Ayabe, T., López-Boado, Y.S., Stratman, J.L., Hultgren, S.J., Matrisian, L.M., Parks, W.C., Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286 (1999), 113–117.
100. [100] Schroeder, B.O., Wu, Z., Nuding, S., Groscurth, S., Marcinowski, M., Beisner, J., Buchner, J., Schaller, M., Stange, E.F., Wehkamp, J., Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1. Nature 469 (2011), 419–423, 10.1038/nature09674.
101. [101] Damiano, S., Morano, A., Ucci, V., Accetta, R., Mondola, P., Paternò, R., Avvedimento, V.E., Santillo, M., Dual oxidase 2 generated reactive oxygen species selectively mediate the induction of mucins by epidermal growth factor in enterocytes. Int. J. Biochem. Cell Biol. 60 (2015), 8–18, 10.1016/j.biocel.2014.12.014.
102. [102] Alam, A., Leoni, G., Wentworth, C.C., Kwal, J.M., Wu, H., Ardita, C.S., Swanson, P.A., Lambeth, J.D., Jones, R.M., Nusrat, A., Neish, A.S., Redox signaling regulates commensal-mediated mucosal homeostasis and restitution and requires formyl peptide receptor 1. Mucosal Immunol. 7 (2014), 645–655, 10.1038/mi.2013.84.
103. [103] Babbin, B.A., Jesaitis, A.J., Ivanov, A.I., Kelly, D., Laukoetter, M., Nava, P., Parkos, C.A., Nusrat, A., Formyl peptide receptor-1 activation enhances intestinal epithelial cell restitution through phosphatidylinositol 3-kinase-dependent activation of Rac1 and Cdc42. J. Immunol. 179 (2007), 8112–8121.
104. [104] Babbin, B.A., Lee, W.Y., Parkos, C.A., Winfree, L.M., Akyildiz, A., Perretti, M., Nusrat, A., Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J. Biol. Chem. 281 (2006), 19588–19599, 10.1074/jbc.M513025200.
105. [105] Leoni, G., Alam, A., Neumann, P.-A., Lambeth, J.D., Cheng, G., McCoy, J., Hilgarth, R.S., Kundu, K., Murthy, N., Kusters, D., Reutelingsperger, C., Perretti, M., Parkos, C.A., Neish, A.S., Nusrat, A., Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J. Clin. Investig. 123 (2013), 443–454, 10.1172/JCI65831.
106. [106] Bäckhed, F., Ley, R.E., Sonnenburg, J.L., Peterson, D.A., Gordon, J.I., Host-bacterial mutualism in the human intestine. Science 307 (2005), 1915–1920, 10.1126/science.1104816.
107. [107] Gill, S.R., Pop, M., Deboy, R.T., Eckburg, P.B., Turnbaugh, P.J., Samuel, B.S., Gordon, J.I., Relman, D.A., Fraser-Liggett, C.M., Nelson, K.E., Metagenomic analysis of the human distal gut microbiome. Science 312 (2006), 1355–1359, 10.1126/science.1124234.
108. [108] Dethlefsen, L., McFall-Ngai, M., Relman, D.A., An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449 (2007), 811–818, 10.1038/nature06245.
109. [109] Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E., Relman, D.A., Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638, 10.1126/science.1110591.
110. [110] Xu, J., Mahowald, M.A., Ley, R.E., Lozupone, C.A., Hamady, M., Martens, E.C., Henrissat, B., Coutinho, P.M., Minx, P., Latreille, P., Cordum, H., Van Brunt, A., Kim, K., Fulton, R.S., Fulton, L.A., Clifton, S.W., Wilson, R.K., Knight, R.D., Gordon, J.I., Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol., 5, 2007, e156, 10.1371/journal.pbio.0050156.
111. [111] Hooper, L.V., Gordon, J.I., Commensal host-bacterial relationships in the gut. Science 292 (2001), 1115–1118.
112. [112] Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L., De Simone, C., Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121 (2001), 580–591.
113. [113] Neish, A.S., Microbes in gastrointestinal health and disease. Gastroenterology 136 (2009), 65–80, 10.1053/j.gastro.2008.10.080.
114. [114] M. Wilson, The gastrointestinal tract and its indigenous microbiota, in: Microbial Inhabitants of Humans, 1st edition, Cambridge University Press, New York, 2004, pp. 251–317.
115. [115] Hooper, L.V., Wong, M.H., Thelin, A., Hansson, L., Falk, P.G., Gordon, J.I., Molecular analysis of commensal host-microbial relationships in the intestine. Science 291 (2001), 881–884, 10.1126/science.291.5505.881.
116. [116] Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., Medzhitov, R., Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 (2004), 229–241, 10.1016/j.cell.2004.07.002.
117. [117] Lee, J., Mo, J.-H., Katakura, K., Alkalay, I., Rucker, A.N., Liu, Y.-T., Lee, H.-K., Shen, C., Cojocaru, G., Shenouda, S., Kagnoff, M., Eckmann, L., Ben-Neriah, Y., Raz, E., Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat. Cell Biol. 8 (2006), 1327–1336, 10.1038/ncb1500.
118. [118] Lambeth, J.D., NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4 (2004), 181–189, 10.1038/nri1312.
119. [119] Bedard, K., Krause, K.-H., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87 (2007), 245–313, 10.1152/physrev.00044.2005.
120. [120] Jones, R.M., Luo, L., Ardita, C.S., Richardson, A.N., Kwon, Y.M., Mercante, J.W., Alam, A., Gates, C.L., Wu, H., Swanson, P.A., Lambeth, J.D., Denning, P.W., Neish, A.S., Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J. 32 (2013), 3017–3028, 10.1038/emboj.2013.224.
121. [121] Swanson, P.A., Kumar, A., Samarin, S., Vijay-Kumar, M., Kundu, K., Murthy, N., Hansen, J., Nusrat, A., Neish, A.S., Enteric commensal bacteria potentiate epithelial restitution via reactive oxygen species-mediated inactivation of focal adhesion kinase phosphatases. Proc. Natl. Acad. Sci. USA 108 (2011), 8803–8808, 10.1073/pnas.1010042108.
122. [122] Wentworth, C.C., Alam, A., Jones, R.M., Nusrat, A., Neish, A.S., Enteric commensal bacteria induce extracellular signal-regulated kinase pathway signaling via formyl peptide receptor-dependent redox modulation of dual specific phosphatase 3. J. Biol. Chem. 286 (2011), 38448–38455, 10.1074/jbc.M111.268938.
123. [123] Kumar, A., Wu, H., Collier-Hyams, L.S., Hansen, J.M., Li, T., Yamoah, K., Pan, Z.-Q., Jones, D.P., Neish, A.S., Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J. 26 (2007), 4457–4466, 10.1038/sj.emboj.7601867.
124. [124] Neish, A.S., Gewirtz, A.T., Zeng, H., Young, A.N., Hobert, M.E., Karmali, V., Rao, A.S., Madara, J.L., Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289 (2000), 1560–1563.
125. [125] Collier-Hyams, L.S., Sloane, V., Batten, B.C., Neish, A.S., Cutting edge: bacterial modulation of epithelial signaling via changes in neddylation of cullin-1. J. Immunol. 175 (2005), 4194–4198.
126. [126] Lee, W.-J., Bacterial-modulated signaling pathways in gut homeostasis. Sci. Signal., 1, 2008, pe24, 10.1126/stke.121pe24.
127. [127] Rada, P., Rojo, A.I., Offergeld, A., Feng, G.J., Velasco-Martín, J.P., González-Sancho, J.M., Valverde, Á.M., Dale, T., Regadera, J., Cuadrado, A., WNT-3A regulates an Axin1/NRF2 complex that regulates antioxidant metabolism in hepatocytes. Antioxid. Redox Signal. 22 (2015), 555–571, 10.1089/ars.2014.6040.
128. [128] Jones, R.M., Desai, C., Darby, T.M., Luo, L., Wolfarth, A.A., Scharer, C.D., Ardita, C.S., Reedy, A.R., Keebaugh, E.S., Neish, A.S., Lactobacilli modulate epithelial cytoprotection through the Nrf2 pathway. Cell Rep. 12 (2015), 1217–1225, 10.1016/j.celrep.2015.07.042.
129. [129] Wilson, K.T., Fu, S., Ramanujam, K.S., Meltzer, S.J., Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res. 58 (1998), 2929–2934.
130. [130] Sharma, P., Clinical practice. Barrett's esophagus. N. Engl. J. Med. 361 (2009), 2548–2556, 10.1056/NEJMcp0902173.
131. [131] Kong, J., Whelan, K.A., Laczkó, D., Dang, B., Caro Monroig, A., Soroush, A., Falcone, J., Amaravadi, R.K., Rustgi, A.K., Ginsberg, G.G., Falk, G.W., Nakagawa, H., Lynch, J.P., Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress. Mol. Carcinog., 2015, 10.1002/mc.22406.
132. [132] Buas, M.F., He, Q., Johnson, L.G., Onstad, L., Levine, D.M., Thrift, A.P., Gharahkhani, P., Palles, C., Lagergren, J., Fitzgerald, R.C., Ye, W., Caldas, C., Bird, N.C., Shaheen, N.J., Bernstein, L., Gammon, M.D., Wu, A.H., Hardie, L.J., Pharoah, P.D., Liu, G., Iyer, P., Corley, D.A., Risch, H.A., Chow, W.-H., Prenen, H., Chegwidden, L., Love, S., Attwood, S., Moayyedi, P., MacDonald, D., Harrison, R., Watson, P., Barr, H., deCaestecker, J., Tomlinson, I., Jankowski, J., Whiteman, D.C., MacGregor, S., Vaughan, T.L., Madeleine, M.M., Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. Gut, 2016, 10.1136/gutjnl-2016-311622.
133. [133] Song, S., Guha, S., Liu, K., Buttar, N.S., Bresalier, R.S., COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma. Gut 56 (2007), 1512–1521, 10.1136/gut.2007.121244.
134. [134] Baruah, A., Buttar, N., Chandra, R., Chen, X., Clemons, N.J., Compare, D., El-Rifai, W., Gu, J., Houchen, C.W., Koh, S.Y., Li, W., Nardone, G., Phillips, W.A., Sharma, A., Singh, I., Upton, M.P., Vega, K.J., Wu, X., Translational research on Barrett's esophagus. Ann. N. Y. Acad. Sci. 1325 (2014), 170–186, 10.1111/nyas.12531.
135. [135] Wetscher, G.J., Hinder, R.A., Bagchi, D., Hinder, P.R., Bagchi, M., Perdikis, G., McGinn, T., Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am. J. Surg., 170, 1995 (552-556-557).
136. [136] Wetscher, G.J., Hinder, R.A., Klingler, P., Gadenstätter, M., Perdikis, G., Hinder, P.R., Reflux esophagitis in humans is a free radical event. Dis. Esophagus 10 (1997), 29–32 (discussion 33).
137. [137] Jiménez, P., Piazuelo, E., Sánchez, M.T., Ortego, J., Soteras, F., Lanas, A., Free radicals and antioxidant systems in reflux esophagitis and Barrett's esophagus. World J. Gastroenterol. 11 (2005), 2697–2703.
138. [138] Wetscher, G.J., Perdikis, G., Kretchmar, D.H., Stinson, R.G., Bagchi, D., Redmond, E.J., Adrian, T.E., Hinder, R.A., Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig. Dis. Sci. 40 (1995), 1297–1305.
139. [139] Piazuelo, E., Cebrián, C., Escartín, A., Jiménez, P., Soteras, F., Ortego, J., Lanas, A., Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus. World J. Gastroenterol. 11 (2005), 7436–7443.
140. [140] Song, J.H., Han, Y.-M., Kim, W.H., Park, J.-M., Jeong, M., Go, E.J., Hong, S.P., Hahm, K.B., Oxidative stress from reflux esophagitis to esophageal cancer: the alleviation with antioxidants. Free Radic. Res., 2016, 1–12, 10.1080/10715762.2016.1181262.
141. [141] Fu, X., Beer, D.G., Behar, J., Wands, J., Lambeth, D., Cao, W., cAMP-response element-binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J. Biol. Chem. 281 (2006), 20368–20382, 10.1074/jbc.M603353200.
142. [142] Hong, J., Li, D., Cao, W., Rho kinase ROCK2 mediates Acid-Induced NADPH oxidase NOX5-S expression in human esophageal adenocarcinoma cells. PLoS One, 11, 2016, e0149735, 10.1371/journal.pone.0149735.
143. [143] Li, D., Cao, W., Role of intracellular calcium and NADPH oxidase NOX5-S in acid-induced DNA damage in Barrett's cells and Barrett's esophageal adenocarcinoma cells. Am. J. Physiol. Gastrointest. Liver Physiol. 306 (2014), G863–872, 10.1152/ajpgi.00321.2013.
144. [144] Peng, D., Hu, T., Soutto, M., Belkhiri, A., Zaika, A., El-Rifai, W., Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma. Gut 63 (2014), 540–551, 10.1136/gutjnl-2013-304612.
145. [145] Peng, D., Belkhiri, A., Hu, T., Chaturvedi, R., Asim, M., Wilson, K.T., Zaika, A., El-Rifai, W., Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells. Gut 61 (2012), 1250–1260, 10.1136/gutjnl-2011-301078.
146. [146] Peng, D.-F., Hu, T.-L., Soutto, M., Belkhiri, A., El-Rifai, W., Loss of glutathione peroxidase 7 promotes TNF-α-induced NF-κB activation in Barrett's carcinogenesis. Carcinogenesis 35 (2014), 1620–1628, 10.1093/carcin/bgu083.
147. [147] Wetscher, G.J., Hinder, P.R., Bagchi, D., Perdikis, G., Redmond, E.J., Glaser, K., Adrian, T.E., Hinder, R.A., Free radical scavengers prevent reflux esophagitis in rats. Dig. Dis. Sci. 40 (1995), 1292–1296.
148. [148] Hong, J., Chen, Z., Peng, D., Zaika, A., Revetta, F., Washington, M.K., Belkhiri, A., El-Rifai, W., APE1-mediated DNA damage repair provides survival advantage for esophageal adenocarcinoma cells in response to acidic bile salts. Oncotarget 7 (2016), 16688–16702, 10.18632/oncotarget.7696.
149. [149] Malfertheiner, P., Chan, F.K., McColl, K.E., Peptic ulcer disease. Lancet 374 (2009), 1449–1461, 10.1016/S0140-6736(09)60938-7.
150. [150] Sandler, R.S., Everhart, J.E., Donowitz, M., Adams, E., Cronin, K., Goodman, C., Gemmen, E., Shah, S., Avdic, A., Rubin, R., The burden of selected digestive diseases in the United States. Gastroenterology 122 (2002), 1500–1511.
151. [151] Soreide, K., Thorsen, K., Harrison, E.M., Bingener, J., Moller, M.H., Ohene-Yeboah, M., Soreide, J.A., Perforated peptic ulcer. Lancet 386 (2015), 1288–1298, 10.1016/S0140-6736(15)00276-7.
152. [152] Yuan, Y., Padol, I.T., Hunt, R.H., Peptic ulcer disease today. Nat. Clin. Pract. Gastroenterol. Hepatol. 3 (2006), 80–89, 10.1038/ncpgasthep0393.
153. [153] Nomura, A., Stemmermann, G.N., Chyou, P.H., Perez-Perez, G.I., Blaser, M.J., Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann. Intern. Med. 120 (1994), 977–981.
154. [154] Kuipers, E.J., Thijs, J.C., Festen, H.P., The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment. Pharmacol. Ther. 9:Suppl 2 (1995), S59–S69.
155. [155] Ford, A., Delaney, B., Forman, D., Moayyedi, P., Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst. Rev., 4, 2004, CD003840, 10.1002/14651858.CD003840.pub2.
156. [156] Ford, A.C., Delaney, B.C., Forman, D., Moayyedi, P., Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst. Rev., 2, 2006, CD003840, 10.1002/14651858.CD003840.pub4.
157. [157] Marshall, B.J., Warren, J.R., Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1 (1984), 1311–1315.
158. [158] Kusters, J.G., van Vliet, A.H.M., Kuipers, E.J., Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 19 (2006), 449–490, 10.1128/CMR.00054-05.
159. [159] Moss, S.F., Legon, S., Bishop, A.E., Polak, J.M., Calam, J., Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 340 (1992), 930–932.
160. [160] el-Omar, E.M., Penman, I.D., Ardill, J.E., Chittajallu, R.S., Howie, C., McColl, K.E., Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109 (1995), 681–691.
161. [161] Mooney, C., Keenan, J., Munster, D., Wilson, I., Allardyce, R., Bagshaw, P., Chapman, B., Chadwick, V., Neutrophil activation by Helicobacter pylori. Gut 32 (1991), 853–857.
162. [162] Crowe, S.E., Alvarez, L., Dytoc, M., Hunt, R.H., Muller, M., Sherman, P., Patel, J., Jin, Y., Ernst, P.B., Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 108 (1995), 65–74.
163. [163] Zhang, Q.B., Nakashabendi, I.M., Mokhashi, M.S., Dawodu, J.B., Gemmell, C.G., Russell, R.I., Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis. Gut 38 (1996), 841–845.
164. [164] Zhang, Q.B., Dawodu, J.B., Husain, A., Etolhi, G., Gemmell, C.G., Russell, R.I., Association of antral mucosal levels of interleukin 8 and reactive oxygen radicals in patients infected with Helicobacter pylori. Clin. Sci. 92 (1997), 69–73.
165. [165] Blaser, M.J., Perez-Perez, G.I., Kleanthous, H., Cover, T.L., Peek, R.M., Chyou, P.H., Stemmermann, G.N., Nomura, A., Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55 (1995), 2111–2115.
166. [166] Manente, L., Perna, A., Buommino, E., Altucci, L., Lucariello, A., Citro, G., Baldi, A., Iaquinto, G., Tufano, M.A., De Luca, A., The Helicobacter pylori's protein VacA has direct effects on the regulation of cell cycle and apoptosis in gastric epithelial cells. J. Cell. Physiol. 214 (2008), 582–587, 10.1002/jcp.21242.
167. [167] Davies, G.R., Simmonds, N.J., Stevens, T.R., Grandison, A., Blake, D.R., Rampton, D.S., Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 33 (1992), 1467–1472.
168. [168] Davies, G.R., Simmonds, N.J., Stevens, T.R., Sheaff, M.T., Banatvala, N., Laurenson, I.F., Blake, D.R., Rampton, D.S., Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 35 (1994), 179–185.
169. [169] Suzuki, H., Miura, S., Imaeda, H., Suzuki, M., Han, J.Y., Mori, M., Fukumura, D., Tsuchiya, M., Ishii, H., Enhanced levels of chemiluminescence and platelet activating factor in urease-positive gastric ulcers. Free Radic. Biol. Med. 20 (1996), 449–454.
170. [170] Kawahara, T., Teshima, S., Oka, A., Sugiyama, T., Kishi, K., Rokutan, K., Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect. Immun. 69 (2001), 4382–4389, 10.1128/IAI.69.7.4382-4389.2001.
171. [171] Kawahara, T., Kohjima, M., Kuwano, Y., Mino, H., Teshima-Kondo, S., Takeya, R., Tsunawaki, S., Wada, A., Sumimoto, H., Rokutan, K., Helicobacter pylori lipopolysaccharide activates Rac1 and transcription of NADPH oxidase Nox1 and its organizer NOXO1 in guinea pig gastric mucosal cells. Am. J. Physiol. Cell Physiol. 288 (2005), C450–457, 10.1152/ajpcell.00319.2004.
172. [172] Chu, S.H., Kim, H., Seo, J.Y., Lim, J.W., Mukaida, N., Kim, K.H., Role of NF-kappaB and AP-1 on helicobater pylori-induced IL-8 expression in AGS cells. Dig. Dis. Sci. 48 (2003), 257–265.
173. [173] O'Hara, A.M., Bhattacharyya, A., Mifflin, R.C., Smith, M.F., Ryan, K.A., Scott, K.G.-E., Naganuma, M., Casola, A., Izumi, T., Mitra, S., Ernst, P.B., Crowe, S.E., Interleukin-8 induction by Helicobacter pylori in gastric epithelial cells is dependent on apurinic/apyrimidinic endonuclease-1/redox factor-1. J. Immunol. 177 (2006), 7990–7999.
174. [174] Keenan, J.I., Peterson, R.A., Hampton, M.B., NADPH oxidase involvement in the pathology of Helicobacter pylori infection. Free Radic. Biol. Med. 38 (2005), 1188–1196, 10.1016/j.freeradbiomed.2004.12.025.
175. [175] Götz, J.M., Thio, J.L., Verspaget, H.W., Offerhaus, G.J., Biemond, I., Lamers, C.B., Veenendaal, R.A., Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases. Gut 40 (1997), 591–596.
176. [176] Suzuki, H., Mori, M., Seto, K., Kai, A., Kawaguchi, C., Suzuki, M., Suematsu, M., Yoneta, T., Miura, S., Ishii, H., Helicobacter pylori-associated gastric pro- and antioxidant formation in Mongolian gerbils. Free Radic. Biol. Med. 26 (1999), 679–684.
177. [177] Smoot, D.T., Elliott, T.B., Verspaget, H.W., Jones, D., Allen, C.R., Vernon, K.G., Bremner, T., Kidd, L.C., Kim, K.S., Groupman, J.D., Ashktorab, H., Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury. Carcinogenesis 21 (2000), 2091–2095.
178. [178] Kimura, M., Goto, S., Ihara, Y., Wada, A., Yahiro, K., Niidome, T., Aoyagi, H., Hirayama, T., Kondo, T., Impairment of glutathione metabolism in human gastric epithelial cells treated with vacuolating cytotoxin from Helicobacter pylori. Microb. Pathog. 31 (2001), 29–36, 10.1006/mpat.2001.0446.
179. [179] Shirin, H., Pinto, J.T., Liu, L.U., Merzianu, M., Sordillo, E.M., Moss, S.F., Helicobacter pylori decreases gastric mucosal glutathione. Cancer Lett. 164 (2001), 127–133.
180. [180] Bhattacharjee, M., Bhattacharjee, S., Gupta, A., Banerjee, R.K., Critical role of an endogenous gastric peroxidase in controlling oxidative damage in H. pylori-mediated and nonmediated gastric ulcer. Free Radic. Biol. Med. 32 (2002), 731–743.
181. [181] Drake, I.M., Mapstone, N.P., Schorah, C.J., White, K.L., Chalmers, D.M., Dixon, M.F., Axon, A.T., Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: relation to gastric mucosal ascorbic acid concentrations and effect of H pylori eradication. Gut 42 (1998), 768–771.
182. [182] Buommino, E., Donnarumma, G., Manente, L., De Filippis, A., Silvestri, F., Iaquinto, S., Tufano, M.A., De Luca, A., The Helicobacter pylori protein HspB interferes with Nrf2/Keap1 pathway altering the antioxidant response of Ags cells. Helicobacter 17 (2012), 417–425, 10.1111/j.1523-5378.2012.00973.x.
183. [183] Iaquinto, G., Todisco, A., Giardullo, N., D'Onofrio, V., Pasquale, L., De Luca, A., Andriulli, A., Perri, F., Rega, C., De Chiara, G., Landi, M., Taccone, W., Leandro, G., Figura, N., Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development. Dig. Liver Dis. 32 (2000), 378–383.
184. [184] Gong, M., Ling, S.S., Lui, S.Y., Yeoh, K.G., Ho, B., Helicobacter pylori gamma-glutamyl transpeptidase is a pathogenic factor in the development of peptic ulcer disease. Gastroenterology 139 (2010), 564–573, 10.1053/j.gastro.2010.03.050.
185. [185] Mita, M., Satoh, M., Shimada, A., Okajima, M., Azuma, S., Suzuki, J.S., Sakabe, K., Hara, S., Himeno, S., Metallothionein is a crucial protective factor against Helicobacter pylori-induced gastric erosive lesions in a mouse model. Am. J. Physiol. Gastrointest. Liver Physiol. 294 (2008), G877–84, 10.1152/ajpgi.00251.2007.
186. [186] Ding, S.-Z., Minohara, Y., Fan, X.J., Wang, J., Reyes, V.E., Patel, J., Dirden-Kramer, B., Boldogh, I., Ernst, P.B., Crowe, S.E., Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells. Infect. Immun. 75 (2007), 4030–4039, 10.1128/IAI.00172-07.
187. [187] Calvino-Fernandez, M., Benito-Martinez, S., Parra-Cid, T., Oxidative stress by Helicobacter pylori causes apoptosis through mitochondrial pathway in gastric epithelial cells. Apoptosis 13 (2008), 1267–1280, 10.1007/s10495-008-0255-0.
188. [188] Ding, S.-Z., O'Hara, A.M., Denning, T.L., Dirden-Kramer, B., Mifflin, R.C., Reyes, V.E., Ryan, K.A., Elliott, S.N., Izumi, T., Boldogh, I., Mitra, S., Ernst, P.B., Crowe, S.E., Helicobacter pylori and H2O2 increase AP endonuclease-1/redox factor-1 expression in human gastric epithelial cells. Gastroenterology 127 (2004), 845–858.
189. [189] den Hartog, G., Chattopadhyay, R., Ablack, A., Hall, E.H., Butcher, L.D., Bhattacharyya, A., Eckmann, L., Harris, P.R., Das, S., Ernst, P.B., Crowe, S.E., Regulation of Rac1 and reactive oxygen species production in response to infection of gastrointestinal epithelia. PLoS Pathog., 12, 2016, e1005382, 10.1371/journal.ppat.1005382.
190. [190] Fu, S., Ramanujam, K.S., Wong, A., Fantry, G.T., Drachenberg, C.B., James, S.P., Meltzer, S.J., Wilson, K.T., Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 116 (1999), 1319–1329.
191. [191] Zhang, X., Ruiz, B., Correa, P., Miller, M.J., Cellular dissociation of NF-kappaB and inducible nitric oxide synthase in Helicobacter pylori infection. Free Radic. Biol. Med. 29 (2000), 730–735.
192. [192] Lim, J.W., Kim, H., Kim, K.H., NF-kappaB, inducible nitric oxide synthase and apoptosis by Helicobacter pylori infection. Free Radic. Biol. Med. 31 (2001), 355–366.
193. [193] Lu, D.Y., Tang, C.H., Chang, C.H., Maa, M.C., Fang, S.H., Hsu, Y.M., Lin, Y.H., Lin, C.J., Lee, W.C., Lin, H.J., Lee, C.H., Lai, C.H., Helicobacter pylori attenuates lipopolysaccharide-induced nitric oxide production by murine macrophages. Innate Immun. 18 (2012), 406–417, 10.1177/1753425911413164.
194. [194] Gobert, A.P., McGee, D.J., Akhtar, M., Mendz, G.L., Newton, J.C., Cheng, Y., Mobley, H.L., Wilson, K.T., Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc. Natl. Acad. Sci. USA 98 (2001), 13844–13849, 10.1073/pnas.241443798.
195. [195] Nagata, K., Yu, H., Nishikawa, M., Kashiba, M., Nakamura, A., Sato, E.F., Tamura, T., Inoue, M., Helicobacter pylori generates superoxide radicals and modulates nitric oxide metabolism. J. Biol. Chem. 273 (1998), 14071–14073.
196. [196] Elfvin, A., Edebo, A., Hallersund, P., Casselbrant, A., Fandriks, L., Oxidative and nitrosative stress enzymes in relation to nitrotyrosine in Helicobacter pylori-infected humans. World J. Gastrointest. Pathophysiol. 5 (2014), 373–379, 10.4291/wjgp.v5.i3.373.
197. [197] Brzozowski, T., Konturek, P.C., Konturek, S.J., Brzozowska, I., Pawlik, T., Role of prostaglandins in gastroprotection and gastric adaptation. J. Physiol. Pharmacol. 56:Suppl 5 (2005), S33–S55.
198. [198] Wallace, J.L., Keenan, C.M., Granger, D.N., Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am. J. Physiol. 259 (1990), G462–7.
199. [199] Yadav, S.K., Adhikary, B., Chand, S., Maity, B., Bandyopadhyay, S.K., Chattopadhyay, S., Molecular mechanism of indomethacin-induced gastropathy. Free Radic. Biol. Med. 52 (2012), 1175–1187, 10.1016/j.freeradbiomed.2011.12.023.
200. [200] Yoshikawa, T., Naito, Y., Kishi, A., Tomii, T., Kaneko, T., Iinuma, S., Ichikawa, H., Yasuda, M., Takahashi, S., Kondo, M., Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut 34 (1993), 732–737.
201. [201] Biswas, K., Bandyopadhyay, U., Chattopadhyay, I., Varadaraj, A., Ali, E., Banerjee, R.K., A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J. Biol. Chem. 278 (2003), 10993–11001, 10.1074/jbc.M210328200.
202. [202] Chattopadhyay, I., Bandyopadhyay, U., Biswas, K., Maity, P., Banerjee, R.K., Indomethacin inactivates gastric peroxidase to induce reactive-oxygen-mediated gastric mucosal injury and curcumin protects it by preventing peroxidase inactivation and scavenging reactive oxygen. Free Radic. Biol. Med. 40 (2006), 1397–1408, 10.1016/j.freeradbiomed.2005.12.016.
203. [203] Maity, P., Bindu, S., Dey, S., Goyal, M., Alam, A., Pal, C., Mitra, K., Bandyopadhyay, U., Indomethacin, a non-steroidal anti-inflammatory drug, develops gastropathy by inducing reactive oxygen species-mediated mitochondrial pathology and associated apoptosis in gastric mucosa: a novel role of mitochondrial aconitase oxidation. J. Biol. Chem. 284 (2009), 3058–3068, 10.1074/jbc.M805329200.
204. [204] Tan, A., Nakamura, H., Kondo, N., Tanito, M., Kwon, Y.-W., Ahsan, M.K., Matsui, H., Narita, M., Yodoi, J., Thioredoxin-1 attenuates indomethacin-induced gastric mucosal injury in mice. Free Radic. Res. 41 (2007), 861–869, 10.1080/10715760701199618.
205. [205] Aburaya, M., Tanaka, K.-I., Hoshino, T., Tsutsumi, S., Suzuki, K., Makise, M., Akagi, R., Mizushima, T., Heme oxygenase-1 protects gastric mucosal cells against non-steroidal anti-inflammatory drugs. J. Biol. Chem. 281 (2006), 33422–33432, 10.1074/jbc.M602074200.
206. [206] Ueda, K., Ueyama, T., Yoshida, K., Kimura, H., Ito, T., Shimizu, Y., Oka, M., Tsuruo, Y., Ichinose, M., Adaptive HNE-Nrf2-HO-1 pathway against oxidative stress is associated with acute gastric mucosal lesions. Am. J. Physiol. Gastrointest. Liver Physiol. 295 (2008), G460–9, 10.1152/ajpgi.00204.2007.
207. [207] Bindu, S., Pal, C., Dey, S., Goyal, M., Alam, A., Iqbal, M.S., Dutta, S., Sarkar, S., Kumar, R., Maity, P., Bandyopadhyay, U., Translocation of heme oxygenase-1 to mitochondria is a novel cytoprotective mechanism against non-steroidal anti-inflammatory drug-induced mitochondrial oxidative stress, apoptosis, and gastric mucosal injury. J. Biol. Chem. 286 (2011), 39387–39402, 10.1074/jbc.M111.279893.
208. [208] Bindu, S., Mazumder, S., Dey, S., Pal, C., Goyal, M., Alam, A., Iqbal, M.S., Sarkar, S., Azhar Siddiqui, A., Banerjee, C., Bandyopadhyay, U., Nonsteroidal anti-inflammatory drug induces proinflammatory damage in gastric mucosa through NF-kappaB activation and neutrophil infiltration: anti-inflammatory role of heme oxygenase-1 against nonsteroidal anti-inflammatory drug. Free Radic. Biol. Med. 65 (2013), 456–467, 10.1016/j.freeradbiomed.2013.07.027.
209. [209] Yadav, S.K., Adhikary, B., Bandyopadhyay, S.K., Chattopadhyay, S., Inhibition of TNF-alpha, and NF-kappaB and JNK pathways accounts for the prophylactic action of the natural phenolic, allylpyrocatechol against indomethacin gastropathy. Biochim. Biophys. Acta 2013 (1830), 3776–3786, 10.1016/j.bbagen.2013.03.013.
210. [210] Pan, M.R., Hung, W.C., Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription. J. Biol. Chem. 277 (2002), 32775–32780, 10.1074/jbc.M202334200.
211. [211] Swarnakar, S., Ganguly, K., Kundu, P., Banerjee, A., Maity, P., Sharma, A.V., Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J. Biol. Chem. 280 (2005), 9409–9415, 10.1074/jbc.M413398200.
212. [212] Ganguly, K., Kundu, P., Banerjee, A., Reiter, R.J., Swarnakar, S., Hydrogen peroxide-mediated downregulation of matrix metalloprotease-2 in indomethacin-induced acute gastric ulceration is blocked by melatonin and other antioxidants. Free Radic. Biol. Med. 41 (2006), 911–925, 10.1016/j.freeradbiomed.2006.04.022.
213. [213] Nelson, K.K., Melendez, J.A., Mitochondrial redox control of matrix metalloproteinases. Free Radic. Biol. Med. 37 (2004), 768–784, 10.1016/j.freeradbiomed.2004.06.008.
214. [214] Eberhardt, W., Schulze, M., Engels, C., Klasmeier, E., Pfeilschifter, J., Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-kappaB and Ets transcription factors. Mol. Endocrinol. 16 (2002), 1752–1766, 10.1210/me.2001-0278.
215. [215] Correa, P., Houghton, J., Carcinogenesis of Helicobacter pylori. Gastroenterology 133 (2007), 659–672, 10.1053/j.gastro.2007.06.026.
216. [216] Correa, P., A human model of gastric carcinogenesis. Cancer Res. 48 (1988), 3554–3560.
217. [217] Crowe, S.E., Helicobacter infection, chronic inflammation, and the development of malignancy. Curr. Opin. Gastroenterol. 21 (2005), 32–38.
218. [218] Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., Schlemper, R.J., Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345 (2001), 784–789, 10.1056/NEJMoa001999.
219. [219] Minoura-Etoh, J., Gotoh, K., Sato, R., Ogata, M., Kaku, N., Fujioka, T., Nishizono, A., Helicobacter pylori-associated oxidant monochloramine induces reactivation of Epstein-Barr virus (EBV) in gastric epithelial cells latently infected with EBV. J. Med. Microbiol. 55 (2006), 905–911, 10.1099/jmm.0.46580-0.
220. [220] Parsonnet, J., Friedman, G.D., Orentreich, N., Vogelman, H., Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40 (1997), 297–301.
221. [221] Huang, J.Q., Zheng, G.F., Sumanac, K., Irvine, E.J., Hunt, R.H., Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 125 (2003), 1636–1644.
222. [222] Ogura, K., Maeda, S., Nakao, M., Watanabe, T., Tada, M., Kyutoku, T., Yoshida, H., Shiratori, Y., Omata, M., Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J. Exp. Med. 192 (2000), 1601–1610.
223. [223] Teshima, S., Tsunawaki, S., Rokutan, K., Helicobacter pylori lipopolysaccharide enhances the expression of NADPH oxidase components in cultured guinea pig gastric mucosal cells. FEBS Lett. 452 (1999), 243–246.
224. [224] Montalvo-Javé, E.E., Olguín-Martínez, M., Hernández-Espinosa, D.R., Sánchez-Sevilla, L., Mendieta-Condado, E., Contreras-Zentella, M.L., Oñate-Ocaña, L.F., Escalante-Tatersfield, T., Echegaray-Donde, A., Ruiz-Molina, J.M., Herrera, M.F., Morán, J., Hernández-Muñoz, R., Role of NADPH oxidases in inducing a selective increase of oxidant stress and cyclin D1 and checkpoint 1 over-expression during progression to human gastric adenocarcinoma. Eur. J. Cancer 57 (2016), 50–57, 10.1016/j.ejca.2015.11.027.
225. [225] Chaturvedi, R., Asim, M., Piazuelo, M.B., Yan, F., Barry, D.P., Sierra, J.C., Delgado, A.G., Hill, S., Casero, R.A., Bravo, L.E., Dominguez, R.L., Correa, P., Polk, D.B., Washington, M.K., Rose, K.L., Schey, K.L., Morgan, D.R., Peek, R.M., Wilson, K.T., Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage. Gastroenterology 146 (2014), 1739–1751, 10.1053/j.gastro.2014.02.005.
226. [226] Futagami, S., Hiratsuka, T., Shindo, T., Horie, A., Hamamoto, T., Suzuki, K., Kusunoki, M., Miyake, K., Gudis, K., Crowe, S.E., Tsukui, T., Sakamoto, C., Expression of apurinic/apyrimidinic endonuclease-1 (APE-1) in H. pylori-associated gastritis, gastric adenoma, and gastric cancer. Helicobacter 13 (2008), 209–218, 10.1111/j.1523-5378.2008.00605.x.
227. [227] Chattopadhyay, R., Bhattacharyya, A., Crowe, S.E., Dual regulation by apurinic/apyrimidinic endonuclease-1 inhibits gastric epithelial cell apoptosis during Helicobacter pylori infection. Cancer Res. 70 (2010), 2799–2808, 10.1158/0008-5472.CAN-09-4136.
228. [228] Bhattacharyya, A., Chattopadhyay, R., Burnette, B.R., Cross, J.V., Mitra, S., Ernst, P.B., Bhakat, K.K., Crowe, S.E., Acetylation of apurinic/apyrimidinic endonuclease-1 regulates Helicobacter pylori-mediated gastric epithelial cell apoptosis. Gastroenterology 136 (2009), 2258–2269, 10.1053/j.gastro.2009.02.014.
229. [229] Bhattacharyya, A., Chattopadhyay, R., Hall, E.H., Mebrahtu, S.T., Ernst, P.B., Crowe, S.E., Mechanism of hypoxia-inducible factor 1 alpha-mediated Mcl1 regulation in Helicobacter pylori-infected human gastric epithelium. Am. J. Physiol. Gastrointest. Liver Physiol. 299 (2010), G1177–86, 10.1152/ajpgi.00372.2010.
230. [230] Lefebvre, O., Chenard, M.P., Masson, R., Linares, J., Dierich, A., LeMeur, M., Wendling, C., Tomasetto, C., Chambon, P., Rio, M.C., Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274 (1996), 259–262.
231. [231] Calnan, D.P., Westley, B.R., May, F.E., Floyd, D.N., Marchbank, T., Playford, R.J., The trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS. J. Pathol. 188 (1999), 312–317, 10.1002/(SICI)1096-9896(199907)188:3<312::AID-PATH360>3.0.CO;2-P.
232. [232] Soutto, M., Belkhiri, A., Piazuelo, M.B., Schneider, B.G., Peng, D., Jiang, A., Washington, M.K., Kokoye, Y., Crowe, S.E., Zaika, A., Correa, P., Peek, R.M., El-Rifai, W., Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans. J. Clin. Investig. 121 (2011), 1753–1767, 10.1172/JCI43922.
233. [233] Jarry, A., Bach-Ngohou, K., Masson, D., Dejoie, T., Lehur, P.-A., Mosnier, J.-F., Denis, M.G., Laboisse, C.L., Human colonic myocytes are involved in postischemic inflammation through ADAM17-dependent TNFalpha production. Br. J. Pharmacol. 147 (2006), 64–72, 10.1038/sj.bjp.0706449.
234. [234] Tunc, T., Uysal, B., Atabek, C., Kesik, V., Caliskan, B., Oztas, E., Ersoz, N., Oter, S., Guven, A., Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury. J. Surg. Res. 155 (2009), 210–216, 10.1016/j.jss.2008.06.017.
235. [235] Parks, D.A., Bulkley, G.B., Granger, D.N., Hamilton, S.R., McCord, J.M., Ischemic injury in the cat small intestine: role of superoxide radicals. Gastroenterology 82 (1982), 9–15.
236. [236] Parks, D.A., Granger, D.N., Contributions of ischemia and reperfusion to mucosal lesion formation. Am. J. Physiol. 250 (1986), G749–753.
237. [237] Victoni, T., Coelho, F.R., Soares, A.L., de Freitas, A., Secher, T., Guabiraba, R., Erard, F., de Oliveira-Filho, R.M., Vargaftig, B.B., Lauvaux, G., Kamal, M.A., Ryffel, B., Moser, R., Tavares-de-Lima, W., Local and remote tissue injury upon intestinal ischemia and reperfusion depends on the TLR/MyD88 signaling pathway. Med. Microbiol. Immunol. 199 (2010), 35–42, 10.1007/s00430-009-0134-5.
238. [238] Higgins, P.D.R., Davis, K.J., Laine, L., Systematic review: the epidemiology of ischaemic colitis. Aliment. Pharmacol. Ther. 19 (2004), 729–738, 10.1111/j.1365-2036.2004.01903.x.
239. [239] Marsh, M.N., Clinical and pathological spectrum of coeliac disease. Gut, 34, 1993, 1740 (author reply 1741).
240. [240] Rewers, M., Eisenbarth, G.S., Autoimmunity: celiac disease in T1DM-the need to look long term. Nat. Rev. Endocrinol. 8 (2012), 7–8, 10.1038/nrendo.2011.193.
241. [241] Rubio-Tapia, A., Ludvigsson, J.F., Brantner, T.L., Murray, J.A., Everhart, J.E., The prevalence of celiac disease in the United States. Am. J. Gastroenterol. 107 (2012), 1538–1544, 10.1038/ajg.2012.219.
242. [242] Green, P.H.R., Cellier, C., Celiac disease. N. Engl. J. Med. 357 (2007), 1731–1743, 10.1056/NEJMra071600.
243. [243] Scanlon, S.A., Murray, J.A., Update on celiac disease – etiology, differential diagnosis, drug targets, and management advances. Clin. Exp. Gastroenterol. 4 (2011), 297–311, 10.2147/CEG.S8315.
244. [244] Leffler, D.A., Dennis, M., Hyett, B., Kelly, E., Schuppan, D., Kelly, C.P., Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin. Gastroenterol. Hepatol. 5 (2007), 445–450, 10.1016/j.cgh.2006.12.006.
245. [245] Sollid, L.M., Molecular basis of celiac disease. Annu. Rev. Immunol. 18 (2000), 53–81, 10.1146/annurev.immunol.18.1.53.
246. [246] van Heel, D.A., West, J., Recent advances in coeliac disease. Gut 55 (2006), 1037–1046, 10.1136/gut.2005.075119.
247. [247] Vader, W., Stepniak, D., Kooy, Y., Mearin, L., Thompson, A., van Rood, J.J., Spaenij, L., Koning, F., The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc. Natl. Acad. Sci. USA 100 (2003), 12390–12395, 10.1073/pnas.2135229100.
248. [248] van Heel, D.A., Franke, L., Hunt, K.A., Gwilliam, R., Zhernakova, A., Inouye, M., Wapenaar, M.C., Barnardo, M.C.N.M., Bethel, G., Holmes, G.K.T., Feighery, C., Jewell, D., Kelleher, D., Kumar, P., Travis, S., Walters, J.R.F., Sanders, D.S., Howdle, P., Swift, J., Playford, R.J., McLaren, W.M., Mearin, M.L., Mulder, C.J., McManus, R., McGinnis, R., Cardon, L.R., Deloukas, P., Wijmenga, C., A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat. Genet. 39 (2007), 827–829, 10.1038/ng2058.
249. [249] Bodd, M., Kim, C.-Y., Lundin, K.E.A., Sollid, L.M., T-cell response to gluten in patients with HLA-DQ20.2 reveals requirement of peptide-MHC stability in celiac disease. Gastroenterology 142 (2012), 552–561, 10.1053/j.gastro.2011.11.021.
250. [250] Barone, M.V., Troncone, R., Auricchio, S., Gliadin peptides as triggers of the proliferative and stress/innate immune response of the celiac small intestinal mucosa. Int. J. Mol. Sci. 15 (2014), 20518–20537, 10.3390/ijms151120518.
251. [251] Shan, L., Molberg, Ø., Parrot, I., Hausch, F., Filiz, F., Gray, G.M., Sollid, L.M., Khosla, C., Structural basis for gluten intolerance in celiac sprue. Science 297 (2002), 2275–2279, 10.1126/science.1074129.
252. [252] Ciccocioppo, R., Di Sabatino, A., Corazza, G.R., The immune recognition of gluten in coeliac disease. Clin. Exp. Immunol. 140 (2005), 408–416, 10.1111/j.1365-2249.2005.02783.x.
253. [253] Molberg, O., Mcadam, S.N., Körner, R., Quarsten, H., Kristiansen, C., Madsen, L., Fugger, L., Scott, H., Norén, O., Roepstorff, P., Lundin, K.E., Sjöström, H., Sollid, L.M., Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 4 (1998), 713–717.
254. [254] Setty, M., Discepolo, V., Abadie, V., Kamhawi, S., Mayassi, T., Kent, A., Ciszewski, C., Maglio, M., Kistner, E., Bhagat, G., Semrad, C., Kupfer, S.S., Green, P.H., Guandalini, S., Troncone, R., Murray, J.A., Turner, J.R., Jabri, B., Distinct and synergistic contributions of epithelial stress and adaptive immunity to functions of intraepithelial killer cells and active celiac disease. Gastroenterology 149 (2015), 681–691, 10.1053/j.gastro.2015.05.013.
255. [255] Maiuri, L., Ciacci, C., Ricciardelli, I., Vacca, L., Raia, V., Auricchio, S., Picard, J., Osman, M., Quaratino, S., Londei, M., Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362 (2003), 30–37, 10.1016/S0140-6736(03)13803-2.
256. [256] DePaolo, R.W., Abadie, V., Tang, F., Fehlner-Peach, H., Hall, J.A., Wang, W., Marietta, E.V., Kasarda, D.D., Waldmann, T.A., Murray, J.A., Semrad, C., Kupfer, S.S., Belkaid, Y., Guandalini, S., Jabri, B., Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 471 (2011), 220–224, 10.1038/nature09849.
257. [257] Caputo, I., Secondo, A., Lepretti, M., Paolella, G., Auricchio, S., Barone, M.V., Esposito, C., Gliadin peptides induce tissue transglutaminase activation and ER-stress through Ca2+ mobilization in Caco-2 cells. PLoS One, 7, 2012, e45209, 10.1371/journal.pone.0045209.
258. [258] Allegretti, Y.L., Bondar, C., Guzman, L., Cueto Rua, E., Chopita, N., Fuertes, M., Zwirner, N.W., Chirdo, F.G., Broad MICA/B expression in the small bowel mucosa: a link between cellular stress and celiac disease. PLoS One, 8, 2013, e73658, 10.1371/journal.pone.0073658.
259. [259] Jabri, B., Kasarda, D.D., Green, P.H.R., Innate and adaptive immunity: the yin and yang of celiac disease. Immunol. Rev. 206 (2005), 219–231, 10.1111/j.0105-2896.2005.00294.x.
260. [260] Odetti, P., Valentini, S., Aragno, I., Garibaldi, S., Pronzato, M.A., Rolandi, E., Barreca, T., Oxidative stress in subjects affected by celiac disease. Free Radic. Res. 29 (1998), 17–24.
261. [261] Stojiljković, V., Todorović, A., Radlović, N., Pejić, S., Mladenović, M., Kasapović, J., Pajović, S.B., Antioxidant enzymes, glutathione and lipid peroxidation in peripheral blood of children affected by coeliac disease. Ann. Clin. Biochem. 44 (2007), 537–543, 10.1258/000456307782268075.
262. [262] Szaflarska-Poplawska, A., Siomek, A., Czerwionka-Szaflarska, M., Gackowski, D., Rózalski, R., Guz, J., Szpila, A., Zarakowska, E., Olinski, R., Oxidatively damaged DNA/oxidative stress in children with celiac disease. Cancer Epidemiol. Biomark. Prev. 19 (2010), 1960–1965, 10.1158/1055-9965.EPI-10-0295.
263. [263] Zimmer, K.-P., Fischer, I., Mothes, T., Weissen-Plenz, G., Schmitz, M., Wieser, H., Büning, J., Lerch, M.M., Ciclitira, P.C., Weber, P., Naim, H.Y., Endocytotic segregation of gliadin peptide 31-49 in enterocytes. Gut 59 (2010), 300–310, 10.1136/gut.2008.169656.
264. [264] Rivabene, R., Mancini, E., De Vincenzi, M., In vitro cytotoxic effect of wheat gliadin-derived peptides on the Caco-2 intestinal cell line is associated with intracellular oxidative imbalance: implications for coeliac disease. Biochim. Biophys. Acta 1453 (1999), 152–160.
265. [265] Luciani, A., Villella, V.R., Vasaturo, A., Giardino, I., Pettoello-Mantovani, M., Guido, S., Cexus, O.N., Peake, N., Londei, M., Quaratino, S., Maiuri, L., Lysosomal accumulation of gliadin p31-43 peptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa. Gut 59 (2010), 311–319, 10.1136/gut.2009.183608.
266. [266] Dolfini, E., Elli, L., Dasdia, T., Bufardeci, B., Colleoni, M.P., Costa, B., Floriani, I., Falini, M.L., Guerrieri, N., Forlani, F., Bardella, M.T., In vitro cytotoxic effect of bread wheat gliadin on the LoVo human adenocarcinoma cell line. Toxicol. In Vitro 16 (2002), 331–337.
267. [267] Stojiljković, V., Todorović, A., Pejić, S., Kasapović, J., Saicić, Z.S., Radlović, N., Pajović, S.B., Antioxidant status and lipid peroxidation in small intestinal mucosa of children with celiac disease. Clin. Biochem. 42 (2009), 1431–1437, 10.1016/j.clinbiochem.2009.06.009.
268. [268] Stazi, A.V., Trinti, B., Selenium deficiency in celiac disease: risk of autoimmune thyroid diseases. Minerva Med. 99 (2008), 643–653.
269. [269] Rothem, L., Hartman, C., Dahan, A., Lachter, J., Eliakim, R., Shamir, R., Paraoxonases are associated with intestinal inflammatory diseases and intracellularly localized to the endoplasmic reticulum. Free Radic. Biol. Med. 43 (2007), 730–739, 10.1016/j.freeradbiomed.2007.05.003.
270. [270] Diosdado, B., van Oort, E., Wijmenga, C., “Coelionomics”: towards understanding the molecular pathology of coeliac disease. Clin. Chem. Lab. Med. 43 (2005), 685–695, 10.1515/CCLM.2005.117.
271. [271] Di Sabatino, A., Ciccocioppo, R., D'Alò, S., Parroni, R., Millimaggi, D., Cifone, M.G., Corazza, G.R., Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease. Gut 49 (2001), 380–386.
272. [272] Maiuri, M.C., De Stefano, D., Mele, G., Iovine, B., Bevilacqua, M.A., Greco, L., Auricchio, S., Carnuccio, R., Gliadin increases iNOS gene expression in interferon-gamma-stimulated RAW 264.7 cells through a mechanism involving NF-kappa B. Naunyn Schmiede. Arch. Pharmacol. 368 (2003), 63–71, 10.1007/s00210-003-0771-y.
273. [273] Maiuri, M.C., De Stefano, D., Mele, G., Fecarotta, S., Greco, L., Troncone, R., Carnuccio, R., Nuclear factor kappa B is activated in small intestinal mucosa of celiac patients. J. Mol. Med. 81 (2003), 373–379, 10.1007/s00109-003-0440-0.
274. [274] De Re, V., Simula, M.P., Notarpietro, A., Canzonieri, V., Cannizzaro, R., Toffoli, G., Do gliadin and tissue transglutaminase mediate PPAR downregulation in intestinal cells of patients with coeliac disease?. Gut 59 (2010), 1730–1731, 10.1136/gut.2010.209395.
275. [275] Flohé, L., Brigelius-Flohé, R., Saliou, C., Traber, M.G., Packer, L., Redox regulation of NF-kappa B activation. Free Radic. Biol. Med. 22 (1997), 1115–1126.
276. [276] ter Steege, J.C., Koster-Kamphuis, L., van Straaten, E.A., Forget, P.P., Buurman, W.A., Nitrotyrosine in plasma of celiac disease patients as detected by a new sandwich ELISA. Free Radic. Biol. Med. 25 (1998), 953–963.
277. [277] Ertekin, V., Selimoğlu, M.A., Türkan, Y., Akçay, F., Serum nitric oxide levels in children with celiac disease. J. Clin. Gastroenterol. 39 (2005), 782–785.
278. [278] van Straaten, E.A., Koster-Kamphuis, L., Bovee-Oudenhoven, I.M., van der Meer, R., Forget, P.P., Increased urinary nitric oxide oxidation products in children with active coeliac disease. Acta Paediatr. 88 (1999), 528–531.
279. [279] Murray, I.A., Daniels, I., Coupland, K., Smith, J.A., Long, R.G., Increased activity and expression of iNOS in human duodenal enterocytes from patients with celiac disease. Am. J. Physiol. Gastrointest. Liver Physiol. 283 (2002), G319–G326, 10.1152/ajpgi.00324.2001.
280. [280] Daniels, I., Cavill, D., Murray, I.A., Long, R.G., Elevated expression of iNOS mRNA and protein in coeliac disease. Clin. Chim. Acta 356 (2005), 134–142, 10.1016/j.cccn.2005.01.029.
281. [281] Beckett, C.G., Dell'Olio, D., Ellis, H.J., Rosen-Bronson, S., Ciclitira, P.J., The detection and localization of inducible nitric oxide synthase production in the small intestine of patients with coeliac disease. Eur. J. Gastroenterol. Hepatol. 10 (1998), 641–647.
282. [282] Han, X., Fink, M.P., Delude, R.L., Proinflammatory cytokines cause NO*-dependent and -independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 19 (2003), 229–237.
283. [283] Montalto, M., Cuoco, L., Ricci, R., Maggiano, N., Vecchio, F.M., Gasbarrini, G., Immunohistochemical analysis of ZO-1 in the duodenal mucosa of patients with untreated and treated celiac disease. Digestion 65 (2002), 227–233 (doi:63817).
284. [284] Ciccocioppo, R., Finamore, A., Ara, C., Di Sabatino, A., Mengheri, E., Corazza, G.R., Altered expression, localization, and phosphorylation of epithelial junctional proteins in celiac disease. Am. J. Clin. Pathol. 125 (2006), 502–511, 10.1309/DTYR-A91G-8R0K-TM8M.
285. [285] Abraham, C., Cho, J.H., Inflammatory bowel disease. N. Engl. J. Med. 361 (2009), 2066–2078, 10.1056/NEJMra0804647.
286. [286] Ordás, I., Eckmann, L., Talamini, M., Baumgart, D.C., Sandborn, W.J., Ulcerative colitis. Lancet 380 (2012), 1606–1619, 10.1016/S0140-6736(12)60150-0.
287. [287] Xavier, R.J., Podolsky, D.K., Unravelling the pathogenesis of inflammatory bowel disease. Nature 448 (2007), 427–434, 10.1038/nature06005.
288. [288] Baumgart, D.C., Sandborn, W.J., Crohn's disease. Lancet 380 (2012), 1590–1605, 10.1016/S0140-6736(12)60026-9.
289. [289] McGovern, D.P.B., Gardet, A., Törkvist, L., Goyette, P., Essers, J., Taylor, K.D., Neale, B.M., Ong, R.T.H., Lagacé, C., Li, C., Green, T., Stevens, C.R., Beauchamp, C., Fleshner, P.R., Carlson, M., D'Amato, M., Halfvarson, J., Hibberd, M.L., Lördal, M., Padyukov, L., Andriulli, A., Colombo, E., Latiano, A., Palmieri, O., Bernard, E.-J., Deslandres, C., Hommes, D.W., de Jong, D.J., Stokkers, P.C., Weersma, R.K., NIDDK IBD Genetics Consortium, Sharma, Y., Silverberg, M.S., Cho, J.H., Wu, J., Roeder, K., Brant, S.R., Schumm, L.P., Duerr, R.H., Dubinsky, M.C., Glazer, N.L., Haritunians, T., Ippoliti, A., Melmed, G.Y., Siscovick, D.S., Vasiliauskas, E.A., Targan, S.R., Annese, V., Wijmenga, C., Pettersson, S., Rotter, J.I., Xavier, R.J., Daly, M.J., Rioux, J.D., Seielstad, M., Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet. 42 (2010), 332–337, 10.1038/ng.549.
290. [290] Biasi, F., Leonarduzzi, G., Oteiza, P.I., Poli, G., Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. Antioxid. Redox Signal. 19 (2013), 1711–1747, 10.1089/ars.2012.4530.
291. [291] Anderson, C.A., Boucher, G., Lees, C.W., Franke, A., D'Amato, M., Taylor, K.D., Lee, J.C., Goyette, P., Imielinski, M., Latiano, A., Lagacé, C., Scott, R., Amininejad, L., Bumpstead, S., Baidoo, L., Baldassano, R.N., Barclay, M., Bayless, T.M., Brand, S., Büning, C., Colombel, J.-F., Denson, L.A., De Vos, M., Dubinsky, M., Edwards, C., Ellinghaus, D., Fehrmann, R.S.N., Floyd, J.A.B., Florin, T., Franchimont, D., Franke, L., Georges, M., Glas, J., Glazer, N.L., Guthery, S.L., Haritunians, T., Hayward, N.K., Hugot, J.-P., Jobin, G., Laukens, D., Lawrance, I., Lémann, M., Levine, A., Libioulle, C., Louis, E., McGovern, D.P., Milla, M., Montgomery, G.W., Morley, K.I., Mowat, C., Ng, A., Newman, W., Ophoff, R.A., Papi, L., Palmieri, O., Peyrin-Biroulet, L., Panés, J., Phillips, A., Prescott, N.J., Proctor, D.D., Roberts, R., Russell, R., Rutgeerts, P., Sanderson, J., Sans, M., Schumm, P., Seibold, F., Sharma, Y., Simms, L.A., Seielstad, M., Steinhart, A.H., Targan, S.R., van den Berg, L.H., Vatn, M., Verspaget, H., Walters, T., Wijmenga, C., Wilson, D.C., Westra, H.-J., Xavier, R.J., Zhao, Z.Z., Ponsioen, C.Y., Andersen, V., Torkvist, L., Gazouli, M., Anagnou, N.P., Karlsen, T.H., Kupcinskas, L., Sventoraityte, J., Mansfield, J.C., Kugathasan, S., Silverberg, M.S., Halfvarson, J., Rotter, J.I., Mathew, C.G., Griffiths, A.M., Gearry, R., Ahmad, T., Brant, S.R., Chamaillard, M., Satsangi, J., Cho, J.H., Schreiber, S., Daly, M.J., Barrett, J.C., Parkes, M., Annese, V., Hakonarson, H., Radford-Smith, G., Duerr, R.H., Vermeire, S., Weersma, R.K., Rioux, J.D., Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 43 (2011), 246–252, 10.1038/ng.764.
292. [292] Mailer, R.K.W., Joly, A.-L., Liu, S., Elias, S., Tegner, J., Andersson, J., IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3. Sci. Rep., 5, 2015, 14674, 10.1038/srep14674.
293. [293] Rogler, G., Brand, K., Vogl, D., Page, S., Hofmeister, R., Andus, T., Knuechel, R., Baeuerle, P.A., Schölmerich, J., Gross, V., Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115 (1998), 357–369.
294. [294] Heller, F., Florian, P., Bojarski, C., Richter, J., Christ, M., Hillenbrand, B., Mankertz, J., Gitter, A.H., Bürgel, N., Fromm, M., Zeitz, M., Fuss, I., Strober, W., Schulzke, J.D., Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129 (2005), 550–564, 10.1016/j.gastro.2005.05.002.
295. [295] Sido, B., Hack, V., Hochlehnert, A., Lipps, H., Herfarth, C., Dröge, W., Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut 42 (1998), 485–492.
296. [296] Cao, W., Vrees, M.D., Kirber, M.T., Fiocchi, C., Pricolo, V.E., Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 286 (2004), G833–843, 10.1152/ajpgi.00414.2003.
297. [297] Ardite, E., Sans, M., Panés, J., Romero, F.J., Piqué, J.M., Fernández-Checa, J.C., Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab. Investig. 80 (2000), 735–744.
298. [298] Loguercio, C., D'Argenio, G., Delle Cave, M., Cosenza, V., Della Valle, N., Mazzacca, G., Del Vecchio Blanco, C., Glutathione supplementation improves oxidative damage in experimental colitis. Dig. Liver Dis. 35 (2003), 635–641.
299. [299] You, Y., Fu, J.-J., Meng, J., Huang, G.-D., Liu, Y.-H., Effect of N-acetylcysteine on the murine model of colitis induced by dextran sodium sulfate through up-regulating PON1 activity. Dig. Dis. Sci. 54 (2009), 1643–1650, 10.1007/s10620-008-0563-9.
300. [300] Biasi, F., Tessitore, L., Zanetti, D., Cutrin, J.C., Zingaro, B., Chiarpotto, E., Zarkovic, N., Serviddio, G., Poli, G., Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression. Gut 50 (2002), 361–367.
301. [301] Biasi, F., Vizio, B., Mascia, C., Gaia, E., Zarkovic, N., Chiarpotto, E., Leonarduzzi, G., Poli, G., C-Jun N-terminal kinase upregulation as a key event in the proapoptotic interaction between transforming growth factor-beta1 and 4-hydroxynonenal in colon mucosa. Free Radic. Biol. Med. 41 (2006), 443–454, 10.1016/j.freeradbiomed.2006.04.005.
302. [302] Kruidenier, L., Kuiper, I., Lamers, C.B.H.W., Verspaget, H.W., Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J. Pathol. 201 (2003), 28–36, 10.1002/path.1409.
303. [303] Tardieu, D., Jaeg, J.P., Deloly, A., Corpet, D.E., Cadet, J., Petit, C.R., The COX-2 inhibitor nimesulide suppresses superoxide and 8-hydroxy-deoxyguanosine formation, and stimulates apoptosis in mucosa during early colonic inflammation in rats. Carcinogenesis 21 (2000), 973–976.
304. [304] D'Incà, R., Cardin, R., Benazzato, L., Angriman, I., Martines, D., Sturniolo, G.C., Oxidative DNA damage in the mucosa of ulcerative colitis increases with disease duration and dysplasia. Inflamm. Bowel Dis. 10 (2004), 23–27.
305. [305] Ding, X., Hiraku, Y., Ma, N., Kato, T., Saito, K., Nagahama, M., Semba, R., Kuribayashi, K., Kawanishi, S., Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease. Cancer Sci. 96 (2005), 157–163, 10.1111/j.1349-7006.2005.00024.x.
306. [306] Meira, L.B., Bugni, J.M., Green, S.L., Lee, C.-W., Pang, B., Borenshtein, D., Rickman, B.H., Rogers, A.B., Moroski-Erkul, C.A., McFaline, J.L., Schauer, D.B., Dedon, P.C., Fox, J.G., Samson, L.D., DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J. Clin. Investig. 118 (2008), 2516–2525, 10.1172/JCI35073.
307. [307] Hussain, S.P., Hofseth, L.J., Harris, C.C., Radical causes of cancer. Nat. Rev. Cancer 3 (2003), 276–285, 10.1038/nrc1046.
308. [308] Naito, Y., Takagi, T., Yoshikawa, T., Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease. J. Gastroenterol. 42 (2007), 787–798, 10.1007/s00535-007-2096-y.
309. [309] Ullman, T.A., Itzkowitz, S.H., Intestinal inflammation and cancer. Gastroenterology 140 (2011), 1807–1816, 10.1053/j.gastro.2011.01.057.
310. [310] Zhu, H., Li, Y.R., Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Exp. Biol. Med. 237 (2012), 474–480, 10.1258/ebm.2011.011358.
311. [311] Mangerich, A., Dedon, P.C., Fox, J.G., Tannenbaum, S.R., Wogan, G.N., Chemistry meets biology in colitis-associated carcinogenesis. Free Radic. Res. 47 (2013), 958–986, 10.3109/10715762.2013.832239.
312. [312] Moret-Tatay, I., Iborra, M., Cerrillo, E., Tortosa, L., Nos, P., Beltrán, B., Possible biomarkers in blood for Crohn's disease: oxidative stress and MicroRNAs-current evidences and further aspects to unravel. Oxid. Med. Cell Longev., 2016, 2016, 2325162, 10.1155/2016/2325162.
313. [313] Banan, A., Zhang, Y., Losurdo, J., Keshavarzian, A., Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line. Gut 46 (2000), 830–837.
314. [314] Banan, A., Smith, G.S., Kokoska, E.R., Miller, T.A., Role of actin cytoskeleton in prostaglandin-induced protection against ethanol in an intestinal epithelial cell line. J. Surg. Res. 88 (2000), 104–113, 10.1006/jsre.1999.5786.
315. [315] Keshavarzian, A., Banan, A., Farhadi, A., Komanduri, S., Mutlu, E., Zhang, Y., Fields, J.Z., Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 52 (2003), 720–728.
316. [316] Wang, A., Keita, Å.V., Phan, V., McKay, C.M., Schoultz, I., Lee, J., Murphy, M.P., Fernando, M., Ronaghan, N., Balce, D., Yates, R., Dicay, M., Beck, P.L., MacNaughton, W.K., Söderholm, J.D., McKay, D.M., Targeting mitochondria-derived reactive oxygen species to reduce epithelial barrier dysfunction and colitis. Am. J. Pathol. 184 (2014), 2516–2527, 10.1016/j.ajpath.2014.05.019.
317. [317] Knutson, C.G., Mangerich, A., Zeng, Y., Raczynski, A.R., Liberman, R.G., Kang, P., Ye, W., Prestwich, E.G., Lu, K., Wishnok, J.S., Korzenik, J.R., Wogan, G.N., Fox, J.G., Dedon, P.C., Tannenbaum, S.R., Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease. Proc. Natl. Acad. Sci. USA 110 (2013), E2332–2341, 10.1073/pnas.1222669110.
318. [318] Muthupalani, S., Ge, Z., Feng, Y., Rickman, B., Mobley, M., McCabe, A., Van Rooijen, N., Fox, J.G., Systemic macrophage depletion inhibits Helicobacter bilis-induced proinflammatory cytokine-mediated typhlocolitis and impairs bacterial colonization dynamics in a BALB/c Rag2-/- mouse model of inflammatory bowel disease. Infect. Immun. 80 (2012), 4388–4397, 10.1128/IAI.00530-12.
319. [319] Rachmilewitz, D., Stamler, J.S., Karmeli, F., Mullins, M.E., Singel, D.J., Loscalzo, J., Xavier, R.J., Podolsky, D.K., Peroxynitrite-induced rat colitis—a new model of colonic inflammation. Gastroenterology 105 (1993), 1681–1688.
320. [320] Binion, D.G., Rafiee, P., Ramanujam, K.S., Fu, S., Fisher, P.J., Rivera, M.T., Johnson, C.P., Otterson, M.F., Telford, G.L., Wilson, K.T., Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion. Free Radic. Biol. Med. 29 (2000), 881–888.
321. [321] Bogdan, C., Nitric oxide and the immune response. Nat. Immunol. 2 (2001), 907–916, 10.1038/ni1001-907.
322. [322] Cross, R.K., Wilson, K.T., Nitric oxide in inflammatory bowel disease. Inflamm. Bowel Dis. 9 (2003), 179–189.
323. [323] Sasaki, M., Bharwani, S., Jordan, P., Elrod, J.W., Grisham, M.B., Jackson, T.H., Lefer, D.J., Alexander, J.S., Increased disease activity in eNOS-deficient mice in experimental colitis. Free Radic. Biol. Med. 35 (2003), 1679–1687.
324. [324] Kawanishi, S., Hiraku, Y., Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid. Redox Signal. 8 (2006), 1047–1058, 10.1089/ars.2006.8.1047.
325. [325] Krieglstein, C.F., Anthoni, C., Cerwinka, W.H., Stokes, K.Y., Russell, J., Grisham, M.B., Granger, D.N., Role of blood- and tissue-associated inducible nitric-oxide synthase in colonic inflammation. Am. J. Pathol. 170 (2007), 490–496, 10.2353/ajpath.2007.060594.
326. [326] Hokari, R., Kato, S., Matsuzaki, K., Kuroki, M., Iwai, A., Kawaguchi, A., Nagao, S., Miyahara, T., Itoh, K., Sekizuka, E., Nagata, H., Ishii, H., Miura, S., Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radic. Biol. Med. 31 (2001), 153–163.
327. [327] Beck, P.L., Xavier, R., Wong, J., Ezedi, I., Mashimo, H., Mizoguchi, A., Mizoguchi, E., Bhan, A.K., Podolsky, D.K., Paradoxical roles of different nitric oxide synthase isoforms in colonic injury. Am. J. Physiol. Gastrointest. Liver Physiol. 286 (2004), G137–147, 10.1152/ajpgi.00309.2003.
328. [328] Tun, X., Yasukawa, K., Yamada, K., Involvement of nitric oxide with activation of Toll-like receptor 4 signaling in mice with dextran sodium sulfate-induced colitis. Free Radic. Biol. Med. 74 (2014), 108–117, 10.1016/j.freeradbiomed.2014.06.020.
329. [329] Minderhoud, I.M., Oldenburg, B., Schipper, M.E.I., ter Linde, J.J.M., Samsom, M., Serotonin synthesis and uptake in symptomatic patients with Crohn's disease in remission. Clin. Gastroenterol. Hepatol. 5 (2007), 714–720, 10.1016/j.cgh.2007.02.013.
330. [330] Regmi, S.C., Park, S.-Y., Ku, S.K., Kim, J.-A., Serotonin regulates innate immune responses of colon epithelial cells through Nox2-derived reactive oxygen species. Free Radic. Biol. Med. 69 (2014), 377–389, 10.1016/j.freeradbiomed.2014.02.003.
331. [331] Ruiz, P.A., Morón, B., Becker, H.M., Lang, S., Atrott, K., Spalinger, M.R., Scharl, M., Wojtal, K.A., Fischbeck-Terhalle, A., Frey-Wagner, I., Hausmann, M., Kraemer, T., Rogler, G., Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome. Gut, 2016, 10.1136/gutjnl-2015-310297.
332. [332] Dhillon, S.S., Fattouh, R., Elkadri, A., Xu, W., Murchie, R., Walters, T., Guo, C., Mack, D., Huynh, H.Q., Baksh, S., Silverberg, M.S., Griffiths, A.M., Snapper, S.B., Brumell, J.H., Muise, A.M., Variants in nicotinamide adenine dinucleotide phosphate oxidase complex components determine susceptibility to very early onset inflammatory bowel disease. Gastroenterology 147 (2014), 680–689, 10.1053/j.gastro.2014.06.005.
333. [333] Rioux, J.D., Xavier, R.J., Taylor, K.D., Silverberg, M.S., Goyette, P., Huett, A., Green, T., Kuballa, P., Barmada, M.M., Datta, L.W., Shugart, Y.Y., Griffiths, A.M., Targan, S.R., Ippoliti, A.F., Bernard, E.-J., Mei, L., Nicolae, D.L., Regueiro, M., Schumm, L.P., Steinhart, A.H., Rotter, J.I., Duerr, R.H., Cho, J.H., Daly, M.J., Brant, S.R., Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39 (2007), 596–604, 10.1038/ng2032.
334. [334] Nair, J., Gansauge, F., Beger, H., Dolara, P., Winde, G., Bartsch, H., Increased etheno-DNA adducts in affected tissues of patients suffering from Crohn's disease, ulcerative colitis, and chronic pancreatitis. Antioxid. Redox Signal. 8 (2006), 1003–1010, 10.1089/ars.2006.8.1003.
335. [335] Kimura, H., Mukaida, M., Kuwabara, K., Ito, T., Hashino, K., Uchida, K., Matsumoto, K., Yoshida, K., 4-Hydroxynonenal modifies IgA in rat intestine after lipopolysaccharide injection. Free Radic. Biol. Med. 41 (2006), 973–978, 10.1016/j.freeradbiomed.2006.06.005.
336. [336] Biasi, F., Mascia, C., Astegiano, M., Chiarpotto, E., Nano, M., Vizio, B., Leonarduzzi, G., Poli, G., Pro-oxidant and proapoptotic effects of cholesterol oxidation products on human colonic epithelial cells: a potential mechanism of inflammatory bowel disease progression. Free Radic. Biol. Med. 47 (2009), 1731–1741, 10.1016/j.freeradbiomed.2009.09.020.
337. [337] Mascia, C., Maina, M., Chiarpotto, E., Leonarduzzi, G., Poli, G., Biasi, F., Proinflammatory effect of cholesterol and its oxidation products on CaCo-2 human enterocyte-like cells: effective protection by epigallocatechin-3-gallate. Free Radic. Biol. Med. 49 (2010), 2049–2057, 10.1016/j.freeradbiomed.2010.09.033.
338. [338] Kruidenier, L., Kuiper, I., van Duijn, W., Marklund, S.L., van Hogezand, R.A., Lamers, C.B.H.W., Verspaget, H.W., Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease. J. Pathol. 201 (2003), 7–16, 10.1002/path.1407.
339. [339] Kruidenier, L., Kuiper, I., Van Duijn, W., Mieremet-Ooms, M.A.C., van Hogezand, R.A., Lamers, C.B.H.W., Verspaget, H.W., Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J. Pathol. 201 (2003), 17–27, 10.1002/path.1408.
340. [340] Te Velde, A.A., Pronk, I., de Kort, F., Stokkers, P.C.F., Glutathione peroxidase 2 and aquaporin 8 as new markers for colonic inflammation in experimental colitis and inflammatory bowel diseases: an important role for H2O2?. Eur. J. Gastroenterol. Hepatol. 20 (2008), 555–560, 10.1097/MEG.0b013e3282f45751.
341. [341] Hiller, F., Besselt, K., Deubel, S., Brigelius-Flohé, R., Kipp, A.P., GPx2 induction is mediated through STAT transcription factors during acute colitis. Inflamm. Bowel Dis. 21 (2015), 2078–2089, 10.1097/MIB.0000000000000464.
342. [342] Kruidenier, L., van Meeteren, M.E., Kuiper, I., Jaarsma, D., Lamers, C.B.H.W., Zijlstra, F.J., Verspaget, H.W., Attenuated mild colonic inflammation and improved survival from severe DSS-colitis of transgenic Cu/Zn-SOD mice. Free Radic. Biol. Med. 34 (2003), 753–765.
343. [343] Esworthy, R.S., Aranda, R., Martín, M.G., Doroshow, J.H., Binder, S.W., Chu, F.F., Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 281 (2001), G848–855.
344. [344] Chu, F.-F., Esworthy, R.S., Chu, P.G., Longmate, J.A., Huycke, M.M., Wilczynski, S., Doroshow, J.H., Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res. 64 (2004), 962–968.
345. [345] Esworthy, R.S., Kim, B.-W., Chow, J., Shen, B., Doroshow, J.H., Chu, F.-F., Nox1 causes ileocolitis in mice deficient in glutathione peroxidase-1 and -2. Free Radic. Biol. Med. 68 (2014), 315–325, 10.1016/j.freeradbiomed.2013.12.018.
346. [346] Banning, A., Florian, S., Deubel, S., Thalmann, S., Müller-Schmehl, K., Jacobasch, G., Brigelius-Flohé, R., GPx2 counteracts PGE2 production by dampening COX-2 and mPGES-1 expression in human colon cancer cells. Antioxid. Redox Signal. 10 (2008), 1491–1500, 10.1089/ars.2008.2047.
347. [347] Higashikubo, A., Tanaka, N., Noda, N., Maeda, I., Yagi, K., Mizoguchi, T., Nanri, H., Increase in thioredoxin activity of intestinal epithelial cells mediated by oxidative stress. Biol. Pharm. Bull. 22 (1999), 900–903.
348. [348] Takahashi, Y., Masuda, H., Ishii, Y., Nishida, Y., Kobayashi, M., Asai, S., Decreased expression of thioredoxin interacting protein mRNA in inflamed colonic mucosa in patients with ulcerative colitis. Oncol. Rep. 18 (2007), 531–535.
349. [349] Jeong, W., Jung, Y., Kim, H., Park, S.J., Rhee, S.G., Thioredoxin-related protein 14, a new member of the thioredoxin family with disulfide reductase activity: implication in the redox regulation of TNF-alpha signaling. Free Radic. Biol. Med. 47 (2009), 1294–1303, 10.1016/j.freeradbiomed.2009.07.021.
350. [350] Andresen, L., Jørgensen, V.L., Perner, A., Hansen, A., Eugen-Olsen, J., Rask-Madsen, J., Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut 54 (2005), 503–509, 10.1136/gut.2003.034165.
351. [351] Visekruna, A., Joeris, T., Seidel, D., Kroesen, A., Loddenkemper, C., Zeitz, M., Kaufmann, S.H.E., Schmidt-Ullrich, R., Steinhoff, U., Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis. J. Clin. Investig. 116 (2006), 3195–3203, 10.1172/JCI28804.
352. [352] Shibata, W., Maeda, S., Hikiba, Y., Yanai, A., Ohmae, T., Sakamoto, K., Nakagawa, H., Ogura, K., Omata, M., Cutting edge: the IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks inflammatory injury in murine colitis. J. Immunol. 179 (2007), 2681–2685.
353. [353] Qiu, W., Wu, B., Wang, X., Buchanan, M.E., Regueiro, M.D., Hartman, D.J., Schoen, R.E., Yu, J., Zhang, L., PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice. J. Clin. Investig. 121 (2011), 1722–1732, 10.1172/JCI42917.
354. [354] Ravi, A., Garg, P., Sitaraman, S.V., Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?. Inflamm. Bowel Dis. 13 (2007), 97–107, 10.1002/ibd.20011.
355. [355] Ye, D., Ma, T.Y., Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-alpha-induced regulation of myosin light chain kinase gene activity. J. Cell. Mol. Med. 12 (2008), 1331–1346, 10.1111/j.1582-4934.2008.00302.x.
356. [356] Kuwano, Y., Tominaga, K., Kawahara, T., Sasaki, H., Takeo, K., Nishida, K., Masuda, K., Kawai, T., Teshima-Kondo, S., Rokutan, K., Tumor necrosis factor alpha activates transcription of the NADPH oxidase organizer 1 (NOXO1) gene and upregulates superoxide production in colon epithelial cells. Free Radic. Biol. Med. 45 (2008), 1642–1652, 10.1016/j.freeradbiomed.2008.08.033.
357. [357] Khor, T.O., Huang, M.-T., Kwon, K.H., Chan, J.Y., Reddy, B.S., Kong, A.-N., Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res. 66 (2006), 11580–11584, 10.1158/0008-5472.CAN-06-3562.
358. [358] Osburn, W.O., Karim, B., Dolan, P.M., Liu, G., Yamamoto, M., Huso, D.L., Kensler, T.W., Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment. Int. J. Cancer 121 (2007), 1883–1891, 10.1002/ijc.22943.
359. [359] Khor, T.O., Huang, M.-T., Prawan, A., Liu, Y., Hao, X., Yu, S., Cheung, W.K.L., Chan, J.Y., Reddy, B.S., Yang, C.S., Kong, A.-N., Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer. Cancer Prev. Res. (Philos.) 1 (2008), 187–191, 10.1158/1940-6207.CAPR-08-0028.
360. [360] Stachel, I., Geismann, C., Aden, K., Deisinger, F., Rosenstiel, P., Schreiber, S., Sebens, S., Arlt, A., Schäfer, H., Modulation of nuclear factor E2-related factor-2 (Nrf2) activation by the stress response gene immediate early response-3 (IER3) in colonic epithelial cells: a novel mechanism of cellular adaption to inflammatory stress. J. Biol. Chem. 289 (2014), 1917–1929, 10.1074/jbc.M113.490920.
361. [361] Marcinkiewicz, J., Ciszek, M., Bobek, M., Strus, M., Heczko, P.B., Kurnyta, M., Biedroń, R., Chmielarczyk, A., Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria. Int. J. Exp. Pathol. 88 (2007), 155–164, 10.1111/j.1365-2613.2007.00530.x.
362. [362] Huycke, M.M., Abrams, V., Moore, D.R., Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 23 (2002), 529–536.
363. [363] Carroll, I.M., Andrus, J.M., Bruno-Bárcena, J.M., Klaenhammer, T.R., Hassan, H.M., Threadgill, D.S., Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 293 (2007), G729–738, 10.1152/ajpgi.00132.2007.
364. [364] Lin, P.W., Myers, L.E.S., Ray, L., Song, S.-C., Nasr, T.R., Berardinelli, A.J., Kundu, K., Murthy, N., Hansen, J.M., Neish, A.S., Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic. Biol. Med. 47 (2009), 1205–1211, 10.1016/j.freeradbiomed.2009.07.033.
365. [365] Elatrech, I., Marzaioli, V., Boukemara, H., Bournier, O., Neut, C., Darfeuille-Michaud, A., Luis, J., Dubuquoy, L., El-Benna, J., My-Chan Dang, P., Marie, J.-C., Escherichia coli LF82 differentially regulates ROS production and mucin expression in intestinal epithelial T84 cells: implication of NOX1. Inflamm. Bowel Dis. 21 (2015), 1018–1026, 10.1097/MIB.0000000000000365.
366. [366] Ballal, S.A., Veiga, P., Fenn, K., Michaud, M., Kim, J.H., Gallini, C.A., Glickman, J.N., Quéré, G., Garault, P., Béal, C., Derrien, M., Courtin, P., Kulakauskas, S., Chapot-Chartier, M.-P., van Hylckama Vlieg, J., Garrett, W.S., Host lysozyme-mediated lysis of Lactococcus lactis facilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons. Proc. Natl. Acad. Sci. USA 112 (2015), 7803–7808, 10.1073/pnas.1501897112.
367. [367] Ravindran, R., Loebbermann, J., Nakaya, H.I., Khan, N., Ma, H., Gama, L., Machiah, D.K., Lawson, B., Hakimpour, P., Wang, Y., Li, S., Sharma, P., Kaufman, R.J., Martinez, J., Pulendran, B., The amino acid sensor GCN2 controls gut inflammation by inhibiting inflammasome activation. Nature 531 (2016), 523–527, 10.1038/nature17186.
368. [368] Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D., Bray, F., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136 (2015), E359–386, 10.1002/ijc.29210.
369. [369] Radtke, F., Clevers, H., Self-renewal and cancer of the gut: two sides of a coin. Science 307 (2005), 1904–1909, 10.1126/science.1104815.
370. [370] Fearon, E.R., Vogelstein, B., A genetic model for colorectal tumorigenesis. Cell 61 (1990), 759–767.
371. [371] O'Brien, C.A., Pollett, A., Gallinger, S., Dick, J.E., A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 (2007), 106–110, 10.1038/nature05372.
372. [372] Ricci-Vitiani, L., Lombardi, D.G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., De Maria, R., Identification and expansion of human colon-cancer-initiating cells. Nature 445 (2007), 111–115, 10.1038/nature05384.
373. [373] Wang, D., Dubois, R.N., The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 29 (2010), 781–788, 10.1038/onc.2009.421.
374. [374] Lewis, J.D., Deren, J.J., Lichtenstein, G.R., Cancer risk in patients with inflammatory bowel disease. Gastroenterol. Clin. N. Am. 28 (1999), 459–477 (x).
375. [375] Izzo, A.A., Camilleri, M., Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut 57 (2008), 1140–1155, 10.1136/gut.2008.148791.
376. [376] Lovasz, B.D., Lakatos, L., Horvath, A., Szita, I., Pandur, T., Mandel, M., Vegh, Z., Golovics, P.A., Mester, G., Balogh, M., Molnar, C., Komaromi, E., Kiss, L.S., Lakatos, P.L., Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort. World J. Gastroenterol. 19 (2013), 2217–2226, 10.3748/wjg.v19.i14.2217.
377. [377] Edin, S., Wikberg, M.L., Dahlin, A.M., Rutegård, J., Öberg, Å., Oldenborg, P.-A., Palmqvist, R., The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS One, 7, 2012, e47045, 10.1371/journal.pone.0047045.
378. [378] Guina, T., Biasi, F., Calfapietra, S., Nano, M., Poli, G., Inflammatory and redox reactions in colorectal carcinogenesis. Ann. N. Y. Acad. Sci. 1340 (2015), 95–103, 10.1111/nyas.12734.
379. [379] Lin, W.-W., Karin, M., A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Investig. 117 (2007), 1175–1183, 10.1172/JCI31537.
380. [380] De Simone, V., Franzè, E., Ronchetti, G., Colantoni, A., Fantini, M.C., Di Fusco, D., Sica, G.S., Sileri, P., MacDonald, T.T., Pallone, F., Monteleone, G., Stolfi, C., Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth. Oncogene 34 (2015), 3493–3503, 10.1038/onc.2014.286.
381. [381] He, Z., He, X., Chen, Z., Ke, J., He, X., Yuan, R., Cai, Z., Chen, X., Wu, X., Lan, P., Activation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in mice. Oncol. Rep. 32 (2014), 1873–1880, 10.3892/or.2014.3421.
382. [382] Karin, M., Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006), 431–436, 10.1038/nature04870.
383. [383] Wu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D.L., Brancati, F.L., Wick, E., McAllister, F., Housseau, F., Pardoll, D.M., Sears, C.L., A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15 (2009), 1016–1022, 10.1038/nm.2015.
384. [384] Arthur, J.C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J.M., Fan, T.-J., Campbell, B.J., Abujamel, T., Dogan, B., Rogers, A.B., Rhodes, J.M., Stintzi, A., Simpson, K.W., Hansen, J.J., Keku, T.O., Fodor, A.A., Jobin, C., Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338 (2012), 120–123, 10.1126/science.1224820.
385. [385] Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L., Albertsen, H., Joslyn, G., Stevens, J., Spirio, L., Robertson, M., Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66 (1991), 589–600.
386. [386] Kinzler, K.W., Nilbert, M.C., Su, L.K., Vogelstein, B., Bryan, T.M., Levy, D.B., Smith, K.J., Preisinger, A.C., Hedge, P., McKechnie, D., Identification of FAP locus genes from chromosome 5q21. Science 253 (1991), 661–665.
387. [387] Powell, S.M., Zilz, N., Beazer-Barclay, Y., Bryan, T.M., Hamilton, S.R., Thibodeau, S.N., Vogelstein, B., Kinzler, K.W., APC mutations occur early during colorectal tumorigenesis. Nature 359 (1992), 235–237, 10.1038/359235a0.
388. [388] Chow, E., Thirlwell, C., Macrae, F., Lipton, L., Colorectal cancer and inherited mutations in base-excision repair. Lancet Oncol. 5 (2004), 600–606, 10.1016/S1470-2045(04)01595-5.
389. [389] Jasperson, K.W., Tuohy, T.M., Neklason, D.W., Burt, R.W., Hereditary and familial colon cancer. Gastroenterology 138 (2010), 2044–2058, 10.1053/j.gastro.2010.01.054.
390. [390] Fodde, R., Brabletz, T., Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr. Opin. Cell Biol. 19 (2007), 150–158, 10.1016/j.ceb.2007.02.007.
391. [391] van Es, J.H., Clevers, H., Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease. Trends Mol. Med. 11 (2005), 496–502, 10.1016/j.molmed.2005.09.008.
392. [392] Thibodeau, S.N., Bren, G., Schaid, D., Microsatellite instability in cancer of the proximal colon. Science 260 (1993), 816–819.
393. [393] Leach, F.S., Nicolaides, N.C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomäki, P., Sistonen, P., Aaltonen, L.A., Nyström-Lahti, M., Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75 (1993), 1215–1225.
394. [394] Bronner, C.E., Baker, S.M., Morrison, P.T., Warren, G., Smith, L.G., Lescoe, M.K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368 (1994), 258–261, 10.1038/368258a0.
395. [395] Howe, J.R., Roth, S., Ringold, J.C., Summers, R.W., Järvinen, H.J., Sistonen, P., Tomlinson, I.P., Houlston, R.S., Bevan, S., Mitros, F.A., Stone, E.M., Aaltonen, L.A., Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280 (1998), 1086–1088.
396. [396] Howe, J.R., Bair, J.L., Sayed, M.G., Anderson, M.E., Mitros, F.A., Petersen, G.M., Velculescu, V.E., Traverso, G., Vogelstein, B., Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat. Genet. 28 (2001), 184–187, 10.1038/88919.
397. [397] Haramis, A.-P.G., Begthel, H., van den Born, M., van Es, J., Jonkheer, S., Offerhaus, G.J.A., Clevers, H., De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 303 (2004), 1684–1686, 10.1126/science.1093587.
398. [398] Kim, B.-G., Li, C., Qiao, W., Mamura, M., Kasprzak, B., Kasperczak, B., Anver, M., Wolfraim, L., Hong, S., Mushinski, E., Potter, M., Kim, S.-J., Fu, X.-Y., Deng, C., Letterio, J.J., Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441 (2006), 1015–1019, 10.1038/nature04846.
399. [399] Fleming, N.I., Jorissen, R.N., Mouradov, D., Christie, M., Sakthianandeswaren, A., Palmieri, M., Day, F., Li, S., Tsui, C., Lipton, L., Desai, J., Jones, I.T., McLaughlin, S., Ward, R.L., Hawkins, N.J., Ruszkiewicz, A.R., Moore, J., Zhu, H.-J., Mariadason, J.M., Burgess, A.W., Busam, D., Zhao, Q., Strausberg, R.L., Gibbs, P., Sieber, O.M., SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. Cancer Res. 73 (2013), 725–735, 10.1158/0008-5472.CAN-12-2706.
400. [400] Barker, N., Ridgway, R.A., van Es, J.H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A.R., Sansom, O.J., Clevers, H., Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457 (2009), 608–611, 10.1038/nature07602.
401. [401] Hendrickse, C.W., Kelly, R.W., Radley, S., Donovan, I.A., Keighley, M.R., Neoptolemos, J.P., Lipid peroxidation and prostaglandins in colorectal cancer. Br. J. Surg. 81 (1994), 1219–1223.
402. [402] Wiseman, H., Halliwell, B., Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313:Pt 1 (1996), 17–29.
403. [403] Skrzydlewska, E., Stankiewicz, A., Sulkowska, M., Sulkowski, S., Kasacka, I., Antioxidant status and lipid peroxidation in colorectal cancer. J. Toxicol. Environ. Health Part A 64 (2001), 213–222, 10.1080/15287390152543690.
404. [404] Yang, H.-Y., Chay, K.-O., Kwon, J., Kwon, S.-O., Park, Y.-K., Lee, T.-H., Comparative proteomic analysis of cysteine oxidation in colorectal cancer patients. Mol. Cells 35 (2013), 533–542, 10.1007/s10059-013-0058-1.
405. [405] Mehrabi, S., Wallace, L., Cohen, S., Yao, X., Aikhionbare, F.O., Differential measurements of oxidatively modified proteins in colorectal adenopolyps. Int. J. Clin. Med. 6 (2015), 288–299, 10.4236/ijcm.2015.64037.
406. [406] Perše, M., Oxidative stress in the pathogenesis of colorectal cancer: cause or consequence?. Biomed. Res. Int., 2013, 2013, 725710, 10.1155/2013/725710.
407. [407] Kondo, S., Toyokuni, S., Iwasa, Y., Tanaka, T., Onodera, H., Hiai, H., Imamura, M., Persistent oxidative stress in human colorectal carcinoma, but not in adenoma. Free Radic. Biol. Med. 27 (1999), 401–410.
408. [408] Lee, D.-H., Esworthy, R.S., Chu, C., Pfeifer, G.P., Chu, F.-F., Mutation accumulation in the intestine and colon of mice deficient in two intracellular glutathione peroxidases. Cancer Res. 66 (2006), 9845–9851, 10.1158/0008-5472.CAN-06-0732.
409. [409] Oliva, M.R., Ripoll, F., Muñiz, P., Iradi, A., Trullenque, R., Valls, V., Drehmer, E., Sáez, G.T., Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community. Mol. Carcinog. 18 (1997), 232–243.
410. [410] Murawaki, Y., Tsuchiya, H., Kanbe, T., Harada, K., Yashima, K., Nozaka, K., Tanida, O., Kohno, M., Mukoyama, T., Nishimuki, E., Kojo, H., Matsura, T., Takahashi, K., Osaki, M., Ito, H., Yodoi, J., Murawaki, Y., Shiota, G., Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett. 259 (2008), 218–230, 10.1016/j.canlet.2007.10.019.
411. [411] Chang, C.L., Marra, G., Chauhan, D.P., Ha, H.T., Chang, D.K., Ricciardiello, L., Randolph, A., Carethers, J.M., Boland, C.R., Oxidative stress inactivates the human DNA mismatch repair system. Am. J. Physiol. Cell Physiol. 283 (2002), C148–154, 10.1152/ajpcell.00422.2001.
412. [412] Barrett, C.W., Reddy, V.K., Short, S.P., Motley, A.K., Lintel, M.K., Bradley, A.M., Freeman, T., Vallance, J., Ning, W., Parang, B., Poindexter, S.V., Fingleton, B., Chen, X., Washington, M.K., Wilson, K.T., Shroyer, N.F., Hill, K.E., Burk, R.F., Williams, C.S., Selenoprotein P influences colitis-induced tumorigenesis by mediating stemness and oxidative damage. J. Clin. Investig. 125 (2015), 2646–2660, 10.1172/JCI76099.
413. [413] Al-Taie, O.H., Uceyler, N., Eubner, U., Jakob, F., Mörk, H., Scheurlen, M., Brigelius-Flohe, R., Schöttker, K., Abel, J., Thalheimer, A., Katzenberger, T., Illert, B., Melcher, R., Köhrle, J., Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis. Nutr. Cancer 48 (2004), 6–14, 10.1207/s15327914nc4801_2.
414. [414] Peters, U., Chatterjee, N., Hayes, R.B., Schoen, R.E., Wang, Y., Chanock, S.J., Foster, C.B., Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol. Biomark. Prev. 17 (2008), 1144–1154, 10.1158/1055-9965.EPI-07-2947.
415. [415] Chu, F.-F., Esworthy, R.S., Doroshow, J.H., Role of Se-dependent glutathione peroxidases in gastrointestinal inflammation and cancer. Free Radic. Biol. Med. 36 (2004), 1481–1495, 10.1016/j.freeradbiomed.2004.04.010.
416. [416] Esworthy, R.S., Yang, L., Frankel, P.H., Chu, F.-F., Epithelium-specific glutathione peroxidase, Gpx2, is involved in the prevention of intestinal inflammation in selenium-deficient mice. J. Nutr. 135 (2005), 740–745.
417. [417] Krehl, S., Loewinger, M., Florian, S., Kipp, A.P., Banning, A., Wessjohann, L.A., Brauer, M.N., Iori, R., Esworthy, R.S., Chu, F.-F., Brigelius-Flohé, R., Glutathione peroxidase-2 and selenium decreased inflammation and tumors in a mouse model of inflammation-associated carcinogenesis whereas sulforaphane effects differed with selenium supply. Carcinogenesis 33 (2012), 620–628, 10.1093/carcin/bgr288.
418. [418] Banning, A., Kipp, A., Schmitmeier, S., Löwinger, M., Florian, S., Krehl, S., Thalmann, S., Thierbach, R., Steinberg, P., Brigelius-Flohé, R., Glutathione peroxidase 2 inhibits cyclooxygenase-2-mediated migration and invasion of HT-29 adenocarcinoma cells but supports their growth as tumors in nude mice. Cancer Res. 68 (2008), 9746–9753, 10.1158/0008-5472.CAN-08-1321.
419. [419] Ahn, B., Ohshima, H., Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production. Cancer Res. 61 (2001), 8357–8360.
420. [420] Rokutan, K., Kawahara, T., Kuwano, Y., Tominaga, K., Sekiyama, A., Teshima-Kondo, S., NADPH oxidases in the gastrointestinal tract: a potential role of Nox1 in innate immune response and carcinogenesis. Antioxid. Redox Signal. 8 (2006), 1573–1582, 10.1089/ars.2006.8.1573.
421. [421] Joo, J.H., Oh, H., Kim, M., An, E.J., Kim, R.-K., Lee, S.-Y., Kang, D.H., Kang, S.W., Keun Park, C., Kim, H., Lee, S.-J., Lee, D., Seol, J.H., Bae, Y.S., NADPH oxidase 1 activity and ROS generation are regulated by Grb2/Cbl-mediated proteasomal degradation of noxo1 in colon cancer cells. Cancer Res. 76 (2016), 855–865, 10.1158/0008-5472.CAN-15-1512.
422. [422] Arbiser, J.L., Petros, J., Klafter, R., Govindajaran, B., McLaughlin, E.R., Brown, L.F., Cohen, C., Moses, M., Kilroy, S., Arnold, R.S., Lambeth, J.D., Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc. Natl. Acad. Sci. USA 99 (2002), 715–720, 10.1073/pnas.022630199.
423. [423] Donald, S.P., Sun, X.Y., Hu, C.A., Yu, J., Mei, J.M., Valle, D., Phang, J.M., Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res. 61 (2001), 1810–1815.
424. [424] Liu, Z., Lu, H., Shi, H., Du, Y., Yu, J., Gu, S., Chen, X., Liu, K.J., Hu, C.-A.A., PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells. Cancer Res. 65 (2005), 1647–1654, 10.1158/0008-5472.CAN-04-1754.
425. [425] Izeradjene, K., Douglas, L., Tillman, D.M., Delaney, A.B., Houghton, J.A., Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines. Cancer Res. 65 (2005), 7436–7445, 10.1158/0008-5472.CAN-04-2628.
426. [426] Leonarduzzi, G., Scavazza, A., Biasi, F., Chiarpotto, E., Camandola, S., Vogel, S., Dargel, R., Poli, G., The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J. 11 (1997), 851–857.
427. [427] Grau, R., Iñiguez, M.A., Fresno, M., Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. Cancer Res. 64 (2004), 5162–5171, 10.1158/0008-5472.CAN-04-0849.
428. [428] Eberhart, C.E., Coffey, R.J., Radhika, A., Giardiello, F.M., Ferrenbach, S., DuBois, R.N., Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 (1994), 1183–1188.
429. [429] Subbaramaiah, K., Dannenberg, A.J., Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol. Sci. 24 (2003), 96–102, 10.1016/S0165-6147(02)00043-3.
430. [430] Iñiguez, M.A., Rodríguez, A., Volpert, O.V., Fresno, M., Redondo, J.M., Cyclooxygenase-2: a therapeutic target in angiogenesis. Trends Mol. Med. 9 (2003), 73–78.
431. [431] Arlt, A., Bauer, I., Schafmayer, C., Tepel, J., Müerköster, S.S., Brosch, M., Röder, C., Kalthoff, H., Hampe, J., Moyer, M.P., Fölsch, U.R., Schäfer, H., Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2). Oncogene 28 (2009), 3983–3996, 10.1038/onc.2009.264.
432. [432] Kim, T.-H., Hur, E., Kang, S.-J., Kim, J.-A., Thapa, D., Lee, Y.M., Ku, S.K., Jung, Y., Kwak, M.-K., NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α. Cancer Res. 71 (2011), 2260–2275, 10.1158/0008-5472.CAN-10-3007.
433. [433] Miar, A., Hevia, D., Muñoz-Cimadevilla, H., Astudillo, A., Velasco, J., Sainz, R.M., Mayo, J.C., Manganese superoxide dismutase (SOD2/MnSOD)/catalase and SOD2/GPx1 ratios as biomarkers for tumor progression and metastasis in prostate, colon, and lung cancer. Free Radic. Biol. Med. 85 (2015), 45–55, 10.1016/j.freeradbiomed.2015.04.001.
434. [434] Was, H., Dulak, J., Jozkowicz, A., Heme oxygenase-1 in tumor biology and therapy. Curr. Drug Targets 11 (2010), 1551–1570.
435. [435] Emmink, B.L., Laoukili, J., Kipp, A.P., Koster, J., Govaert, K.M., Fatrai, S., Verheem, A., Steller, E.J.A., Brigelius-Flohé, R., Jimenez, C.R., Borel Rinkes, I.H.M., Kranenburg, O., GPx2 suppression of H2O2 stress links the formation of differentiated tumor mass to metastatic capacity in colorectal cancer. Cancer Res. 74 (2014), 6717–6730, 10.1158/0008-5472.CAN-14-1645.
436. [436] Darsigny, M., Babeu, J.-P., Seidman, E.G., Gendron, F.-P., Levy, E., Carrier, J., Perreault, N., Boudreau, F., Hepatocyte nuclear factor-4alpha promotes gut neoplasia in mice and protects against the production of reactive oxygen species. Cancer Res. 70 (2010), 9423–9433, 10.1158/0008-5472.CAN-10-1697.
437. [437] Papaioannou, D., Cooper, K.L., Carroll, C., Hind, D., Squires, H., Tappenden, P., Logan, R.F., Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: a systematic review and meta-analysis. Colorectal Dis. 13 (2011), 1085–1099, 10.1111/j.1463-1318.2010.02289.x.